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ABSTRACT 
An experiment was conducted to examine the potential 
interaction of caffeine and psychological stress in human 
subjects. More specifically, subjects comprised of those who 
showed 'high' and 'low' trait anxiety levels as determined by 
administration of the Spielberger Trait - Anxiety Inventory. 
Each student consumed caffeine on a regular basis (2 or more 
cups of coffee and/or tea per day). 
Subjects were run in a single-blind, randomized cross-
over design with caffeine (400mg) and placebo. Each subject 
participated in two, one and a half hour experimental 
sessions held one week apart. 
The cardiovascular effects of a high (400mg) dose of 
caffeine, equivalent to 4 or 5 cups of coffee, were measured 
during periods of rest and psychological stress. The stressor 
involved the administration of a mental arithmetic task 
(serial subtraction) with a set time limit. Subjects were 
challenging required to perform as well as they could 
conditions. In addition, subjects 
"alertness" and "tension" after each part 
under 
reported 
of each 
subjective 
session, 
using lOcm visual analogue scales representing each of these 
two dimensions. 
Previous investigations have documented correlations 
between caffeine intake and variables of heart rate, blood 
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pressure, alertness, tension, and performance, but there has 
been no experimental work comparing the response of high and 
low trait anxiety subjects with respect to these variables. 
Since caffeine is a central nervous system stimulant 
it is reasonable to suggest that the drug could be used as a 
means for low anxiety people to reach an optimal level of 
arousal, and hence perform optimally in a stressful situation 
(eg. exams or public speaking). Likewise, it is equally 
reasonable to suggest that caffeine usage may well be avoided 
by those people who have high anxiety levels if they are to 
perform well. 
The experimental results showed that the order of drug 
presentation proved more than caffeine administration to be 
the most recurrent and important variable involved in inter-
action. Caffeine did not appear to have a potential additive 
effect on the cardiovascular measurements and subjective self 
reports, with that produced by psychological stress. High 
anxiety female subjects showed the greatest elevation in 
resting systolic and diastolic blood pressure with caffeine 
consumption. Low anxiety males showed the greatest elevation 
in diastolic blood pressure with caffeine consumption during 
the stressful situation. High anxiety males and low anxiety 
females showed the greatest elevations in heart rate during 
rest. Males showed greater reported levels of tension with 
caffeine consumption both at rest and during stress, than did 
females. High anxiety subjects showed greater elevations in 
alertness both at rest and during stress following caffeine 
consumption than low anxiety sUbjects. Finally, caffeine 
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consumption was found to have no effect on performance in a 
mental arithmetic task, in both high and low anxiety groups. 
It is concluded from the results that caffeine 
administration (400mg) cannot be used as a means for a low 
anxiety person to reach an optimal drive or stress level to 
perform optimally during a stressful situation. Likewise, 
there was no evidence to suggest that those who have high 
anxiety levels should avoid caffeine consumption to achieve 
such a goal •. 
CHAPTER ONE 
INTRODUCTION 
SOURCE AND HISTORY 
Nonmedically, caffeine is the most widely used central 
nervous system stimulant. Found in a number of plants it is 
contained in beverages and/or flavourings being popular in 
the form of coffee, tea, cocoa and "cola" drinks. 
Caffeine is found in various prescription medications 
and over-the-counter preparations. 
Table I illustrates the common sources of caffeine and 
its approximate concentrations. 
Caffeine is also found in certain noncola softdrinks, 
such as Mellow Yellow, Mountain Dew, and Sunkist Orange, as 
well as in teas containing mate', guarena, and youpon. 
Man discovered caffeine in many forms: 
Coffee was found in Arabia and Turkey; after spreading to 
these and other near Eastern and African regions from 
Ethiopia. 
~ was found in China. 
I 
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The kola nut was found in common use in west Africa, and 
was later introduced into cola drinks as a source of 
caffeine. 
The cocoa tree was discovered in Mexico, the West Indies, 
and much of central and sou.th Africa. Chocolate from this 
tree was the favourite beverage of the Emperor Montezuma; 
it was said that 50 pitcherfuls a day were prepared for 
his use. Throughout the world this drink soon became 
popular. 
The ilex plant, source of the caffeine drink known as 
mate' or Paraguayan tea, was found in Brazil and elsewhere 
in the American tropics. In the United States this tea is 
still drunk as yerba mate', and it rivals coffee and tea 
in popularity in parts of South America. 
Cassina - also known as youpon, the Christmas berry tree, 
and the North American tea plant, was found in common use 
as the source of a caffeine beverage among Indians from 
Virginia to Florida and west along the Gulf coast to the 
Rio Grande. Cheney (1925), reported at the time that 
"none of the Indians but their great Exploits of War and 
Noble Actions, are admitted to the use of this noble 
beveridge." 
White settlers in these regions prepared a tea known as 
the "Black Drink", "Black Drought", or dohoon, from the 
same plant. 
They also produced a drink containing both alcohol and 
caffeine by letting the leaves ferment. 
Table 1 
Common Sources of Caffeine 
Source 
~ages 
Brewed coffee 
Instant coffee 
Brewed black tea 
Brewed green tea 
Instant tea 
Decaffeinated coffee 
Cola drinks 
Cocoa 
Prescription medications 
APGs (asprin, phenacetin, and caffeine) 
Cafergot 
Darvon compound 
Fiorinal 
Migrol 
Over-the-counter preparations 
Anacin, asprin compound, Bromo-Seltzer 
Cope, Easy-Mens, Empirin compound, 
Midol 
Vanquish 
Excedrin 
Pre Mens 
Bromoquinine 
Sinarest 
Dristan 
No Doz 
Vi Varin 
Concentration 
85 mg/ISO ml 
60 mg/ISO ml 
50 mg/ISO ml 
30 mg/ISO ml 
30 mg/ISO ml 
3 mg/ISO ml 
32-65 mg/12 oz 
6-142 mg/ISO ml 
32 mg/tablet 
100 mg/tablet 
32 mg/tablet 
40 mg/tablet 
50 mg/tablet 
32 mg/tablet 
32 mg/tablet 
32 mg/tablet 
60 mg/tablet 
66 mg/tablet 
15 mg/tablet 
30 mg/tablet 
30 mg/tablet 
100 mg/tablet 
100-220 mg/tablet 
3 
Source: Sawyer et al. (1981) (Taken from Stephenson (1977) and Graham 
(1978) • 
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When newly introduced, coffee was considered to be an 
intoxicating brew, dangerous to health. However, coffee 
became a welcome and socially acceptable drink despite 
medical warnings and efforts to suppress it (Stephenson, 
1977). 
The controversey over the health aspects of coffee 
continues. Increasing+y the debate has focused on caffeine. 
Heavy users of caffeine containing beverages report tolerance 
(including cross-tolerance among the Xanthine (Theophylline, 
Caffeine, and Theobromine) beverages), physical dependence 
with withdrawal symptons and craving (Brecher et al., 1972). 
The basis for the popularity of all the caffeine 
containing 
beverages 
elevated 
beverages has been the ancient belief that these 
had stimulant and anti soporific actions that 
mood, decreased fatigue, and increased capacity for 
work (Roll, 1980). 
For example, legend credits the discovery of coffee to 
a prior of an Arabian convent. Shepherds reported that goats 
that had eaten the berries of the coffee plant gamboled and 
frisked about all through the night instead of sleeping. 
Mindful of the long nights of prayer that he had to endure, 
the prior instructed the shepherds to pick the berries so 
that he might make a beverage from them. 
Classical pharmacological studies, principally of 
caffeine during the first half of this century have confirmed 
these .beliefs, and have revealed that Xanthines possess other 
important pharmacological properties as well. 
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Pharmacological Properties 
Caffeine pharmacologically impacts most physiological 
systems. With regard to the central nervous system (CNS), 
caffeine is a power stimulant. Such stimulation undoubtedly 
accounts for the popularity of caffeinatedbeverages. It is 
claimed (Ritchie, 1975; Graham, 1978), that coffee and tea 
promote rapid, clear thinking, improved intellectual effort, 
enhanced mental activity, and decreased drowsiness, fatigue, 
and reaction time - all valued commodities in an achievement 
oriented society. Most of these stimulating actions are 
accounted for by the fact that caffeine affects all parts of 
the cortex. Caffeine also affects the respiratory, 
vasomotor, and vagal centres of the medulla, as well as all 
parts of the spinal cord at high doses. 
Caffeine's action on the cardiovascular system can be 
detected in systemic, coronary, and cerebral circulation 
patterns. The coronary arteries and 
general systemic vessels become dilated 
the pulmonary and 
following caffeine 
ingestion. Heart rate and force of contraction also increase. 
Many of these peripheral effects cannot be observed 
directly, however, because they tend to be masked by central 
stimulating effects upon the medulla. Therefore, at moderate 
doses a person may notice no change in heart rate, no 
tachycardia (rapid beating), or even a slight bradycardia 
(slow beating). 
Caffeine significantly affects gastric secretion 
within the gastrointestinal system which results in prolonged 
enlargement of both volume and acidity. 
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The commonly experienced "coffee diuresis" is a result 
of caffeine's effect on the renal system. 
Finally, caffeine relaxes smooth muscles (especially 
of the bronchi), strengthens the contraction of skeletal 
muscles, and increases basal metabolic rate an average of 10 
per cent among regular coffee drinkers (Brecher at al., 
1972). 
Table. 2 illustrates the Biological effects of 
caffeine. 
Table 2 
Biological Effects of Caffeine 
- Diuretic 
- Cardiac Muscle stimulant 
- Central Nervous System stimulant 
- Smooth Muscle Relaxant 
- Stimulates Fastric Acid Secretion 
- Elevates Plasma Free Fatty Acids and Glucose 
- Pharmacologically Active Dose 200 mg 
- Probably not Mutagenic for Man 
Source: Graham (1978) 
Caffeine and related Xanthines serve a number of specific 
medicinal purposes as listed in Table 3. 
Table 3 
Pharmacological Uses of Caffeine 
and Related Compounds 
Desired Action 
Cerebral stimulation 
Coronary Dilation 
Diuresis 
Respiratory Stimulant 
for Premature Infants 
Source: Graham (1978) 
Preferred Compound 
Caffeine (Coffee) 
Theophylline (Tea) 
Theobromine (Cocoa) 
Caffeine 
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Note that caffeine is preferred as a stimulant, 
theophylline from tea is preferred as a coronary dilator, and 
theobromine from cocoa is preferred as a diuretic (Krontz, 
1954). 
The annual world consumption of coffee exceeds four 
million tons (Robertson et al., 1978). In some countries 
this amount translates into a per capita ingestion of lOOg of 
pure caff eine each year. , 
Dosage is a relevant consideration in the study of 
caffeine pharmacology. Fifty to 200mg of caffeine is 
typically 
actions 
required to 
(Greden, 1974). 
produce expected pharmacological 
Truitt (1971) refers to doses of 
over 250mg as being "large". 
Of clinical significance, this dosage is frequently 
exceeded in everyday life. As indicated in Table 1, caffeine 
is widely available in a mUltiplicity of beverages and 
medications. When cumulatively considered, an individual can 
ingest doses much higher than 250mg often without being 
aware of it. For example, three cups of coffee, two over-
the-counter headache tablets, and o~e cola drink consumed in 
one morning approximates an intake of 500mg caffeine. 
It is easy to 
drinkers dosages would 
amounts. 
see that among heavy coffee or tea 
frequently exceed this by gross 
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Definitive tests have shown that caffeine is not 
adaptive, ie. regular consumption does not diminish its 
stimulant effects. However, caffeine-withdrawal headache is 
well documented. 
The consumption of high levels of caffeine clearly 
becomes a toxic condition. The LD50 of orally administered 
caffeine for the mouse, rat, guinea pig, rabbit, cat, dog and 
hamster has ranged from 100 to 1050mg per kg (Graham, 1978). 
Within recent years, the chronic effects of caffeine 
have been of much interest~ No growth retardation, 
reproductive impairment, nor any other pathological problems 
have been found at levels of 35 to 60mg per kg of body weight 
daily for 26 weeks administered to rats in drinking water. No 
adverse effects on fertility or mortality of rats were 
produced after daily injection with 100mg caffeine per kilo-
gram of body weight for four generations. 
However, higher levels of caffeine near the LD50 , ie. 
150mg per kilogram, produced a variety of pathological 
effects over periods of 100 days; the effects included loss 
of hair, dermotitis, thymic atrophy and congestion of many 
organs (Select Committee on GRAS Substances, 1976). 
Whether any relationship exists between caffeine and 
the pathogenesis of peptic ulcers has long been debated. 
Several experimental animals as well as human subjects in 
single dose experiments have shown stimulation of gastric 
secretion by caffeine. However, a variety of feeding studies 
9 
have failed to establish a clear-cut cause and effect 
relationship between caffeine ingestion and induction or 
~.----/ 
exacerbation of peptic ulcer (Select Committee on GRAS 
substance, 1976). 
Several studies have indicated that caffeine may 
exhibit genetic activity in vitro, but in vivo investigations 
failed to demonstrate mutagenic effects of caffeine (Kreybig 
and van Czok, 1975; Furmanova, 1976; Weathersbee et a1., 
1977; Timson, 1977). 
The transfer of caffeine across the placental barrier 
occurs readily and the developing foetus as well as the 
gonads are subject to the same levels of caffeine present in 
body water of other tissues. In a variety of studies 
teratogenic effects have been shown with laboratory animals 
when caffeine was administered other than by the oral route .. 
However, teratogenic effects were generally absent at oral 
doses of 50mg per kilogram of body weight and lower (Graham, 
1978). 
Major interest has recently been focused on the 
cardiovascular ects of caffeine after the suggestion that 
coffee drinking might be associated with an increased risk of 
myocardial infarction; caffeine ingestion has long been known 
to predispose to extrasysto1es. 
In spite of the widespread consumption of caffeine and 
its broad spectrum of pharmacologic activity, sUbstantial 
gaps in the understanding of its cardiovascular and endocrine 
10 
pharmacology remain. For example, it has been reported to 
increase respiration slightly at high doses (Scott and Chem, 
1944), but has variably been said both to raise (Salla 
Torre et al, 1952), and to lower, (Cotton et al., 1968), the 
heart rate, both to increase (Grollman et al., 1930), and to 
decrease (Starr et al., 1937), the arteriovenous oxygen 
difference, to raise blood pressure and cardiac output (Stepp 
et al., 1938; Ritchie, 1975; Robertson et al., 1978; Lane, 
1983), 
1944). 
and to 
Thus 
elevate oxygen 
contradictions 
consumption 
exist in 
(Haldi et al., 
the literature 
concerning the hemodynamic and humoral effects of the drug in 
man. 
Questions have been raised recently about the possible 
role of caffeine as a cause of cancer. Japanese newspaper 
reports mentioned recent studies indicating that caffeine may 
cause endocrine tumors in female rats (Food Chemicals, 1977). 
Graham (1978) reports that no published scientific studies 
have been found on the influence of caffeine per se on 
carcinogenesis. Studies of coffee drinking in humans and 
feeding of coffee solids to rats show no causal relationship 
between caffeine and cancer (Select Committee on GRAS 
Substances, 1976). 
Performance Effects 
Considering the general availability and widespread 
use of caffeine as a mild stimulant in coffee, tea, and cola 
drinks, few contemporary studies of its ects on human 
performance have been reported. 
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As Regina, Smith, Keiper and McKelvy (1974) have 
indicated, there is a conspicuous lack of contemporary 
literature concerning the drug. 
Graham (1978) characterized caffeine as a 'cortical 
stimulant which relieves fatigue, increases awareness, 
decreases appetite, and often becomes moderately addictive'. 
Caffeine has 
stimulant in that 
and produces few 
been described as an almost ideal 
it enhances cognition and motor activity 
or no side ects for most people 
(Thompson, 1975). Grollman (1951) pointed out that although 
ideas become clearer, thought flows more freely, and fatigue 
and drowsiness disappear, caffeine ingestion often leads to 
inhibition of logical, connected thought, and much effort is 
required to focus attention on a single object~ 
Behavioural effects are partially dependent upon the 
tolerance level of the user, which is increased by chronic 
usage. Doses that increase tolerance result in indigestion, 
nervousness, and insomnia (Leukel, 1972), and these 
disturbances 
pathologies. 
often 
Caffeine has 
are 
been 
antecedents for more serious 
reported to enhance human 
performance in some situations (Baker and Theologus, 1972; 
Franks et al., 1975; Hauty and Payne, 1955; Hollingworth, 
1912; Regina et al., 1974), but not in others (Catell, 1930; 
Cheney, 1935, 1936; Weiss and Laties, 1962). 
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This variability in outcomes suggests that caffeine 
effects may be highly 'task-specific' and raises the question 
of the circumstances under which caffeine produces a 
facilitatory effect. 
The consumption of caffeine in large amounts, is a 
common practice used to overcome drowsiness and forestall 
sleep. Ritchie (1975) has contended that dosages of lOOOmg 
of caffeine are capable of 
referrable in large part to 
producing 
the central 
Restlessness and excitement which may 
delerium with sensory disturbances are said 
responses. 
untoward reactions 
nervous system. 
progress to mild 
to entail such 
In a 1936 case report McManny and Schube describe a 
'caffeine-induced psychotic state'. Greden (1974) directed 
attention to caffeine as an etiologic factor in certain 
anxiety states. 
A case report by Stillner (1978) supported Ritchie's 
contentions about toxic effects of excessive amounts of 
caffeine, and indicates that the common practice of using 
caffeine to stay awake may give rise to a hazardous sequelae. 
As little as five 200mg tablets of readily available over-
the-counter preparations of caffeine appears to be sufficient 
to generate a delerium (ie. experiencing tremor, impaired 
memory, altered Ievels of consciousness, vertigo, pronounced 
anxiety, and sensory disturbances, including visual illusions 
and hallucinations). 
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Even small amounts may lead to sufficient sensory and 
motor disturbances to prove dangerous in situations such as 
long-distance driving. 
Indeed, such e ects of caffeine on behaviour and 
performance merit closer attention. 
Mood Effects 
The perspective gained from previous literature 
regarding the effects of caffeine on anxiety and mood is not 
a clear one. Reports concerning caffeine are mostly based on 
clinical impression. In two of the correlational studies 
(Greden et al., 1978; Winstead, 1976) a positive relationship 
was found between the consumption of caffeine and anxiety. 
However, in two other correlational stUdies (Hire, 1978; 
Lynn, 1973) the relationship was negative. 
Two experimental studies (De Freitas and Schwartz, 
1979; Goldstein et al., 1965) did not control for usual 
consumption and body weight. 
Only two studies have related caffeine consumption to 
mood. A correlational study by Greden et al (1978) with 
psychiatric patients, showed an inverse relationship, while 
Goldstein et al. (1965), in an experimental study, 
demonstrated no effects, although did not control for usual 
consumption or body weight. 
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Furthermore, there is evidence to suggest that the 
effect of caffeine in psychiatric patients could be an 
i'ndirect one through the interference with antipsychotic drug 
effect (Kulhanek et a1., 1979). 
Examining the potential interaction of caffeine and 
psychologic stress in human subjects, Lane (1983) found that 
moderate doses of caffeine (two or three cups of coffee), 
elevated blood pressure in healthy young males during periods 
of rest and stress. Blood pressure during stress was also 
significantly higher after caffeine had been consumed. More 
importantly, the author concludes that the elevation blood 
pressure due to caffeine adds to that elicited by stress. 
Recently a study by Ve1eber and Templer (1984) using 
normal subjects, involved a double blind procedure and 
controlled for body weight and usual consumption. They found 
that consumption of moderate (250mg) doses of caffeine 
increased anxiety, depression, and hostility. 
Although all the studies mentioned do provide us with 
some insight into possible relationships between caffeine 
consumption and mood e ects they have also served to lay a 
foundation upon which future research should be built. 
The general public has been reluctant to classify 
caffeine as a drug, even though 
produces dependence, 
This reflects the 
tolerance, and 
heavy use of caffeine 
withdrawal symptoms. 
drug's "domestication", that is, 
incorporation into our daily life in such rituals as the 
coffee break and the coffee club. 
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There is little doubt that the popularity of caffeine 
containing beverages depends on their stimulant action, 
although most people are unaware of any stimulation. The 
degree to which an individual is stimulated by a given amount 
of caffeine varies. For example, some persons boast of their 
ability to drink several cups of coffee in the evening and 
yet "sleep like a log". On the other hand, there are rare 
persons who are so sensitive to caffeine that even a single 
cup of coffee will cause a response bordering on toxic. 
Very little is known about the effects of caffeine in 
the general population. Is there a normal pattern of usage? 
Are the effects of caffeine consistent in a given population 
or do they vary? Research indicates that there are 
individual differences in tolerance to caffeine and that 
there are interactive effects between caffeine and other 
drugs (Robertson et al., 1978; Jung et al., 1981; Childs, 
1978; Gilliland, 1980; Keisler and McLaughlin, 1972; Revelle 
et al., 1976, 1980). 
Some of the differences in response to caffeine may be 
due to individual differences in the metabolic half-life of 
caffeine (Horning et al., 1977) and differing rates of 
absorption (Robertson et al., 1978). 
Factors such as age, sex, mental state, personality 
type, and degree of physical fitness may effect the way in 
which people differ in response to caffeine. There could be 
differences between racial and ethnic groups, particularly 
those groups where caffeine consumption has been high for 
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centuries as opposed to groups for whom it is a relatively 
new substance. 
Individual differences in response to caff ne may 
well be further understood with information of this kind. 
There is no doubt that a certain degree of tolerance 
(Cotton et al., 1968) and of psychic dependence (ie. 
habituation) develops to caffeine containing beverages. 
This is probably true even in those individuals who do 
not partake to excess. However, the morning cup of coffee is 
so much part of the European and American dietary habit that 
one seldom looks upon its consumption as a drug habit. The 
feeling of well-being and the increased performance it 
affords, although possibly obtained at the expense of 
decreased efficiency later in the day, are experiences that 
few individuals would care to give up. 
CHAPTER TWO 
REVIEW OF THE LITERATURE 
Chemistry of Caffeine 
Caffeine is an alkaloid structurally identied as 1,3, 
7-trimethylxanthine. It is one of several xanthine 
derivatives which occur naturally in coffee beans, tea 
leaves, kola nuts and cocoa beans. Theophylline (1,3-
dimethylxanthine) and theobromine (3,7-dimethylxanthine) are 
also well known. There is close similarity chemically 
between these alkaloids and metabolically important compounds 
such as the purines, xanthine and uric acid. 
Coffee (Coffee arabica) , Tea (Thea sinensis), 
Chocolate (Theobroma cocoa) and kola (Cola nitidia), are the 
most common plants in which caffeine occurs. It is readily 
extracted from these plants and is very soluble in boiling 
water, from which it crystallizes as a monohydrate with one 
molecule of water; from organic solvents it crystallizes as 
an anhydrous material, melting at 235 to 237oC; it sublimes 
at l76 0 C at atmospheric pressure without decomposition. 
Pure caffeine is adourless, has a distinctly bitter 
taste and is 
concentrations 
(Graham, i978). 
stable 
normally 
at temperature, pH and salt 
encountered in food processing 
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PHARMACOLOGICAL PROPERTIES AND 
PHYSIOLOGICAL EFFECTS OF CAFFEINE 
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Caffeine is characterized as a central nervous system 
stimulant. Furthermore, it affects metabolic and 
cardiovascu functions. Caffeine also stimulates the 
adrenal medulla to secrete hormones which themselves are 
known to affect these just mentioned variables and which are 
also closely associated with emotion, stress, and arousal. 
Caffeine acts on the kidney to produce diuresis, 
stimulates cardiac muscle, and relaxes smooth muscle, notably 
bronchial muscle. 
To follow is a brief review of the literature of 
studies concerning caffeine and: 
a) Adrenal Medullary Activity 
b) Respiratory and Cardiovascular effects 
c) Central Nervous System 
d) Smooth Muscle 
e) Skeletal Muscle 
f) Gastric Secretion 
g) Metabolism 
h) Toxicology 
i) Mutagenic effects 
j) Other Illnesses. 
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Adrenal Medullary Activity 
The consumption of caffeine leads to increases in the 
amount of epinephrine and norepinephrine secreted by the 
adrenal medulla (Levi, 1967; Bellet et al., 1969; 
Lentinietat, 1974). Robertson et al. (1978) recorded 
increases in plasma epinehrine (207%), plasma norepinephrine 
(75%), urinary metanephrine (100%), and urinary normetane-
phrine (52%) in nine healthy non-coffee drinkers who had 
fasted overnight and abstained from any caffeine consumption 
in the previous week, one hour after ingesting 250mg of 
caffeine. 
While such increases were substantial and significant, 
Tepperman (1965) pointed out that the adrenal medulla is 
capable of producing increases of up to 1000% during the 
full-blown panic reaction known as the "flight or fight" 
response. 
A number of effects throughout the body occur as a 
result of increases in catecholamine levels. Being a neuro-
transmitter, norepinephrine increases activity at peripheral 
autonomic synapses. It is also found at high concentrations 
in brain structures that have their influence primarily on 
the autonomic nervous system and in some of those involved in 
the motivational and emotional aspects of behaviour 
(Thompson, 1975). 
Responses to epinephrine resemble those produced by 
stimulation of the sympathetic nervous system. Epinephrine 
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has also been associated with emotion. Schacter and Singer 
(1962) found that subjects injected with an epinephrine 
s~lution explained their resulting physiological arousal on 
the basis of cognitive and soc 1 determinants. In the 
presence of someone acting euphorically, subjects interpreted 
their own arousal as euphoria; in the presence of someone 
acting out anger, they interpreted their own arousal as 
anger. Therefore, if the consumption of caffeine increases 
epinephrine levels sufficiently, these increases may 
aggravate whatever the emotional tone of the individual is at 
the time. 
The pattern of epinephrine and norepinephrine levels 
that occur with regular daily ingestion of caffeine also 
needs to be determined. Jung et al. (1981), found that among 
regular coffee drinkers only 3 of 22 subjects after oral 
caffeine ingestion, and in 3 of 14 subjects following 
intravenous caffeine, recorded catecholamine increases of the 
magnitude found in the Robertson et al. (1978) study. 
One could infer from this that the majority of these 
subjects either never showed increases in catecholamines, or, 
had become tolerant and ceased to respond in this way. Since 
there were no significant differences in the coffee-drinking 
behaviour between subjects showing increases in catechol-
amines and other subjects in the study, then elevated 
catecholamine levels and increases arousal s may come to 
be interpreted by such individuals as 'normal'. 
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Increases in epinephrine and norepinephrine would be 
expected to have both physical and emotional consequences in 
the form of increased stress and anxiety. A number of the 
effects of caffeine in humans are consistent with the effects 
of increased levels of epinephrine and/or norepinephrine. 
Caffeine may act as a sympathomimetic drug in some 
people (Sawyer et al., 1981). Sympathomimetic drugs are 
those which cause changes in the body usually associated with 
sympathetic arousal. Through the release of norepinephrine, 
many sympathomimetic drugs act indirectly on the sympathetic 
nervous system. Innes and Nickerson (1975) regarded the 
release of epinephrine from the adrenal glands, as the 
prototype of the sympathomimetic agents. 
Caffeine causes increases in both of these hormones 
and on this basis, Sawyer et al. (1981) hypothesized that it 
is a sympathomimetic agent in some, if not all, individuals. 
Further complications exist as, like caffeine, epinephrine is 
also a central nerous system stimulant. 
Sawyer et al. (198l) argued that a differentiation of 
the effects of caffeine from those of norepinephrine and 
epinephrine as well as determining the manner in which they 
may interact is necessary we are to understand the real 
effects of caffeine. 
Table 4 summarizes the similarities and differences I 
between the reported activity of caffeine and that of 
epinephrine and norepinephrine on various physiological 
variables. 
Table 4 
A Comparison of the Effects of Caffeine, Epinephrine, 
and Norepinephrine on Human Physiology 
Effects reported for: 
Physciological variable Caffeine Epinephrine Norepinephrine 
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Ritchie 
(1975 ) 
Innes and 
Nickerson (1975) 
Innes and 
Nickerson (1975) 
Respiration 
Respiratory rate 
o consumption 
c62 consumption 
Cardiovascular effects 
Heart function 
Rate 
Cardiac output 
Force of contractions 
Cardiac rhythm 
Compensatory vagal 
activity 
Circulation 
Coronary 
Pulmonary 
Skeletal muscle 
Hepatic 
Cutaneous 
Renal 
Cerebral 
Peripheral resistance 
Blood pressure 
CNS stimulation 
Anxiety reaction 
Anxiety 
Restlessness 
Periods of depression 
Tremors 
Flushing 
Diuresis 
Insomnia 
Sensory distrubances 
Skeletal muscle 
Neuromuscular 
transmission 
Power of contractions 
Fatigue 
From Sawyer et al., 1981. 
+ 
+ 
+ 
+,-
+,-
+,-
+,-,0 
Present 
+,-
+,-
+,-
+,-
+,-
+,-
+,-
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
Facil-
itated 
+ 
+ 
+ 
+ 
+ 
+ 
? 
+,-,0 
May be 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
? 
+ 
? 
? 
? 
present 
Facilitated 
+ 
? 
? 
? 
0,-
0,-
? 
+,-,0 
Present 
+ 
? 
0,-
0,-
+ 
+ 
0 
+ 
+ 
? 
+ 
? 
? 
? 
? 
? 
? 
+, increase1 -, decrease; 0, no change; ?, information not given. 
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Sawyer et al. (1981) question whether c feine is a 
sympathomimetic agent, in which case some of its effects 
would be due to increases in catecholamines and not to the 
direct action of caffeine itself. 
Respiratory and Cardiovascular Effects 
Consumption of caffeine leads to increases in 
respiratory rate, oxygen consumption, and carbon dioxide 
elimination as a result of stimulation of the medullary 
respiratory centre (Table 4). 
In a study by Robertson et al. (1978), the respiratory 
rate was determined during a 10 minute interval of quiet 
breathing, of nine healthy non-coffee drinkers following the 
ingestion of 250mg caffeine. Where as the respiratory rate 
60 minutes after placebo averaged 13.4 1.6 (mean ±S.D), the 
comparable value ter caffeine was 16.1 2.3 per minute 
(mean ±S.D). This value was significant at P(0.05 by a paired 
t-test. The degree of respiratory acceleration appeared to 
correlate with plasma caffeine levels over the range observed 
in their subjects (r=0.73, P(O.02). 
All parts of the circulatory system are directly 
effected by caffeine and these actions may be antagonized by 
caffine's stimulation of compensatory vagal centres in the 
medulla. Cardiac muscle is strongly stimulated by caffeine, 
which increases force of contraction, heart rate, and cardiac 
output (Table 4). 
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The effect is masked because the drug also stimulates 
the medullary vagal nuclei, which in turn, decrease heart 
iate. The result of these two opposing actions may be 
bradycardia, tachycardia, 
Stephenson, 1977). 
or no change (Truitt, 1971; 
There also may be variations over time. Caffeine has 
an antagonistic action on the circulation of the blood (Table 
4). Caffeine dilates the coronary, pulmonary, and general 
systemic blood vessels by causing a relaxation of the smooth 
muscle in the vessel walls, it may also constrict blood 
vessels by stimulating the medullary vasomotor centre. No 
compensatory activity on the part of the medulla takes place 
in the brain itself, where caffeine causes a constriction of 
the blood vessels with a decrease in cerebral blood flow 
(Truitt, 1971; Ritchie, 1975). 
The response of blood pressure to caffeine is thought 
to depend on the balance between central vasomotor and 
myocardial stimulation, which tends to increase it, and 
central vagal stimulation and peripheral blood vessel 
dilation, 
Significant 
which tend 
elevations 
to decrease it (Ritchie, 1975). 
in blood pressure were found in 
Robertson's et al. (1978) study, 30 minutes after nine 
healthy male subjects ingested 250mg caffine (Table 4). 
The hyperglycemic action of caffeine has been 
documented. Wachman et al. (1970), demonstrated that a large 
dose of caffeine will diminish glucose tolerance and reduce 
pancreatic insulin release in normal subjects. A similar 
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effect was found by Studlar (1973), particularly in insulin-
dependent diabetic 
ihat blood glucose 
patients. 
dropped 
Naismith et ale (1970), noted 
slightly when caffeine was 
withdrawn and did not return to pretest levels. The work of 
Sandberg and Bellet (1969) did not support the hyperglycerine 
action of c eine; in their studies, normal subjects had 
lower glucose levels when receiving glucose and caffeine than 
when receiving glucose alone. 
higher blood sugar levels were 
However, in diabetic patients, 
found at 30, 60, and 90 
minutes than when receiving glucose alone. 
Free fatty acids may rise after a dose of caffeine 
(Lentini et al., 1974; Naismith et al., 1970; Wachman et al., 
1970). Because they can also fluctuate in response to 
emotional changes, caution is suggested in attaching 
significance to this finding (Naismith et al., 1970). 
Heart rate, blood pressure levels, glucose and fatty 
acid blood concentrations were observed by Handel et ale 
(1977) in six men and six women aged 20-42 years, before and 
within 360 minutes after oral administration of coca cola 
with caffeine (22.5, 35 and 150mg) but without sugar. 
Clinically significant ts (an increase in mean blood 
pressure level, glucose and free fatty acid levels and 
urinary catecholamine excretion) were induced only by 150mg 
of caffeine. 
The results of a study on 50,000 subjects reported by 
Bertrand et ale (1977) demonstrated the absence of a 
relationship between coffee intake and blood pressure 
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elevation. Williamson (1978) has criticized this conclusion 
and enumerated the methodological errors. He has pointed out 
for example, that the authors took the half-life period as 12 
hours though it had not in fact been determined. 
Much interest has developed concerning a possible 
deleterious effect of caffeine in the etiology of acute 
myocardial infarction. An association between myocardial 
infarction and coffee usage has been shown in a u.s. 
surveillance study, and some of these patients are now 
restricted as to caffeine use (Bowan and Rand, 1980). Jick 
and coworkers (1973) reported that individuals drinking more 
than 5 to 6 cups of coffee per day are about twice as liable 
to suffer myocrdia1 infarction. However, in an equally 
careful study K1atsky and associates (1973) found no 
association between coffee drinking and a independent 
subsequent rst myocardial infarction: they suggested that 
the discrepancy in the findings of the two groups may be 
related to factors such as cigarette smoking or the selection 
of control subjects~ Further studies have confirmed that 
coffee drinking is associated with little, if any, increased 
incidence of coronary heart disease (Dowber et a1., 1974; 
Hennekens et a1., 1976). 
The effect of coffee intake on the conductive system 
of the heart has recently been studied for the first time in 
12 patients with organic heart disease in an attempt to 
resolve contradictory data on the cardiovascular effect of 
coffee. ECG was recorded before and 20 minutes after the 
intake of coffee with 150mg of caffeine. It was noted that 
27 
coffee intake lowered the effective and functional refractory 
period of the a/v node, the effect probably being mediated by 
datecholamine release (Gould et al., 1979). 
Multiple measurements of multiple variables should be 
included in the study of c feine and its effects on the 
circulatory system and the medullary centres. As Ritchie 
(1975) stated, "The observation of a single function, for 
example, blood pressure, is deceiving because the drug may 
act on a variety of circulatory factors in such a way that 
blood pressure may remain essentially unchanged." Sawyer et 
al. (1981) added that although caffeine has not been 
associated with an increased frequency of respiratory, 
cardiac, circulatory, or hypertensive disorders (except for 
myocardial infarction (Bowan and Rand, 1980), neither have 
the effects of caffeine on these abnormal populations been 
studied in an experimental setting. Until this is done, the 
assumption that caffeine is not contraindicated for these 
populations will remain an open question. 
Central Nervous System 
Caffeine can stimulate all parts of the central 
nervous system when high enough concentrations are attained 
(Table 4). It is not only the vagal centres in the medulla 
which are affected, but also the cortex and the spinal cord. 
Caffeine stimulates all portions of the cortex. Doses 
of 50 to 200mg can result in increased alertness, decreased 
drowsiness, and lessened fatigue. Doses in the range of 200 
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to 500mg may produce headache, tremors, nervousness, and 
irritability. Hypersethesia, pleasant or unpleasant, may 
occur after excessive coffee intake (Ritchie, 1970; Truitt, 
1971). 
In the course of a series of studies on c eine's 
psychotropic effects Goldstein et ale (1965, 1969) found that 
the drug had no demonstrable effect on objectively measured 
performance, although it made the subjects feel more alert 
and physically active. In some subjects, caffeine caused a 
feeling of "nervousness" rather than alertness. 
There were both qualitative and quantitative 
differences in responses to caffeine that were related to the 
degree of habitual caffeine consumption. Heavy users became 
less jittery and nervous and had fewer headaches with 
increasing doses of caffeine. In the abstainers, caffeine 
produced jitteryness, nervousness, and gastrointestinal 
complaints (Goldstein, 1969). 
The effectiveness of caffeine in preventing attention 
lapses was studied in a visual monitoring test analogous to 
night driving. Caffeine was effective in preventing 
attention lapses after the first hour, and the effect 
persisted over the remaining 2 to 3 hours of the experiment 
(Mitchell et al., 1974). 
Ritchie (1975), summarized the then current attitudes 
about, and research on, the action of caffeine in the 
following terms: 
"Caffeine results in a more rapid and clearer flow 
of thought, and allaying of drowsiness and fatigue. 
After taking caffeine one is capable of a greater 
sustained intellectual effort and a more perfect 
association of ideas. There is also a keener 
appreciation of sensory stimuli, and reaction time 
is appreciably diminished. In addition, motor 
activity is increased: typists, for example, work 
faster and with few errors. II 
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Recent studies show large variations in these effects 
depending on such variables as dosage of caffeine and 
personality type. For example, Revelle et al. (1976) found 
that under 200mg of caffeine and time stress, accuracy of 
extraverts increased while accuracy of introverts decreased 
in a verbal ability test. 
A number of EEG studies concerning caffeine's 
stimulating effect on the cortex show inconsistencies. 
For example, contingent negative variation is a slow 
surface-negative electrical potential of the human brain, and 
its amplitude is related to attention and arousal. Both 
increases (Ashton et al., 1974) and decreases (Jenssen et 
al., 1978) in contingent negative variation amplitudes have 
been reported at comparable time periods (about 30 minutes) 
after the ingestion of 300mg caffeine. 
Looking at other aspects of EEG activity, Klein and 
Salzman (1975), reported reductions in auditory event-
related potentials, 2 hours following the ingestion of 300mg 
caffeine. Walpow and Penny (1978), found that the decreases 
in temporal Nl P2 amplitudes to auditory evoked responses 
usually caused by habituation and fatigue did not occur 
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following caffeine. Thus these results indicate both 
increases and decreases in functions. 
Only after massive doses (probably between 2 and 5gms) 
is the spinal cord stimulated by caffeine (Julien, 1981). 
Increased excitability of spinal reflexes might be observed 
and, at even higher doses, convulsions and death may ensue 
(Ritchie, 1975). The convulsive dose, however, is so high 
(over 10gms, the equivalent of 100 cups of coffee) that death 
from caffeine is highly unlikely. Very few people would 
consume such high amounts of caffeine in the space of a day 
even if they were regular heavy consumers. 
Smooth Muscle 
Caffeine 
blood vessels. 
their ability 
relaxes various muscles other than those of 
The most important action in this respect is 
to relax the smooth muscles of the bronchi, 
especially if the bronchi have been constricted either 
experimentally by histamine or clinically in asthma (Roll, 
1980). 
Skeletal Muscle 
Caffeine has been shown by objective measurements to 
increase the capacity for musclar work in man. Foltz et al. 
(1942), first worked their four subjects to exhaustion on a 
bicycle ergometer. Then, after a 10-minute rest, the 
subjects worked to exhaustion again. The administration of 
SOOmg caffeine during the rest period significantly increased 
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output during the second work period when compared to control 
injections. 
Huidibro and Arnenbar (1945), found that doses of 
3.5mg/kg caffeine increases twitch tension of the indirectly 
stimulated quadriceps muscle of cats. 
Caffeine causes marked increases in tension of 
frequencies slightly below those producing tetanus and is 
accompanied by fusion of individual contractions, perhaps 
owing to a prolonged contraction time (Goffart and Ritchie, 
1952). 
Such observations may be explained in part by the 
ability of caffeine to increase the release of acetylcholine, 
as judged by augmentation of the amplitude and rate of rise 
of end-plate potentials in curarized rat diaphragm (Goldberg 
and Singer, 1969). Caffeine can also increase the resting 
tension of denervated muscle (Huidibro, 1945). 
The site of action of caffeine in the excitation-
contraction coupling process in skeletal muscle has been a 
controversial subject for some time. Axelsson and Thesleff 
(1958) did not observe contraction when caffeine was injected 
intracellularly and they therefore suggested that caffeine 
acted on the plasma membrane. Caldwell and Walstar (1963) 
found, 
elicit 
however, that intracellular injection of caffeine did 
contraction. It was later shown that caffeine 
released bound calcium from sarcoplasmic reticulum isolated 
from skeletal muscle (Weber and Herz, 1968; Ogawa, 1970). As 
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suggested by Luttgow and Oetliker (1968), and by Thorpe and 
Seeman (1971), caffeine nevertheless could exert its effect 
by displacing calcium from the plasma membrane and its 
invaginations, the T tubules. 
Thorpe and Seeman's (1971) results indicated that 
caffeine acts at only one site in the excitation-contraction 
coupling system, the sarcoplasmic reticulum. Caffeine did 
not displace calcium from the sarcolemma, but it did release 
a significant portion of the calcium bound to sarcoplasmic 
reticulum. As reported previously (Weber and Herz, 1968) 
this effect on the reticulum was inhibited by procaine. 
Gast~ic Secretion 
The ability of caffeine to stimulate gastric secretion 
in man is well documented (Roth et al., 1944; Czok, G. 1972; 
Volkheimer et al., 1972; Meiderer et al., 1973; Cohen and 
Booth, 1975). 
Man is relatively sensitive, and moderate oral or 
parental doses of caffeine cause secretion of both acid and 
pepsin (Debas et al., 1971). Patients with active ulcer 
disease can be identified by a sustained elevation of acid 
secretion in response to high doses of caffeine. Normal 
patients show only a transitory rise (Roth et al., 1944). 
Such studies have encouraged the hypothesis that 
excessive use of caffeine-containing beverages, by promoting 
gastric acid secretion, contributes to the pathogenesis of 
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peptic ulcer in the ulcer-prone individual and renders the 
management of the condition more difficult. 
The primary effect probably results from stimulation 
of the gastric myenteric and submucous nerve networks by 
caffeine. A secondary effect is believed to come from the 
central nervous system stimulation via the cholinergic nerve 
fibres. Caffeine has been shown to cause an increase in 
cyclic 3',5' adenosine monophosphate, which appears to be 
involved in the stimulation of hydrogen ion secretion by the 
gastric mucosa (Harris et al., 1965, 1969). 
It has long been known that beverages made from 
roasted grain containing no caffeine stimulate acid secretion 
in man as much as does coffee (Cohnell and Berg, 1931). 
Similarly, Cohen and Booth (1975) demonstrated that both 
decaffeinated coffee and coffee were equally potent in 
stimulating gastric acid secretion. Their results indicated 
that coffee in either form may contain stimulants for acid 
secretion other than caffeine, or possibly a compound which 
potentiates the action of caffeine or a secretagogue which 
acts independently. Czok (1972) attributed these effects to 
caffeine and "Ie sostanze di torrefazione del caffe," the 
compounds resulting from roasting and brewing of coffee. 
In view of the responsiveness of the human gastric 
mucosa to caffeine and other substances in various beverages, 
there should be awareness of the ubiquitous use of coffee and 
colas in the pathogenesis of peptic ulcer and in the 
management of the patient with an ulcer. 
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Metabolism 
After ingestion caffeine is rapidly and essentially 
completely absorbed from the gastrointestinal tract. It 
passes quickly into the central nervous system and into 
various tissues in approximate proportion to their water 
content; tissue response is proportional to caffeine content 
(Axelrod and Reichenthal, 1953). 
Caffeine reaches maximum levels in the blood between 
30 and 120 minutes after ingestion, the mean time being 60 
minutes (Robertson et al., 1978). Among different 
individuals, the metabolic half-life of caffeine varies 
between 4 and 10 hours (Horning et al., 1977) ie. 4 hours 
after ingesting one cup of brewed coffee (85mg caffeine), a 
person with a rapid rate of biotransformation will still have 
a minimum of 42.5mg of caffeine in his/her system. Ingesting 
two more cups of coffee at this time would add l70mg 
caffeine, for a total of 2l2.5mg a figure above the 
pharmacologically active dose given by Graham (1978) as 200mg 
and by Truitt (1971) as between 50 and 200mg. Individuals 
with lower rates of biotransformation would have higher 
levels and would accumulate caffeine more rapidly. This 
difference in turnover rate may be helpful in explaining 
individual differences in response to caffeine. 
Excretion is primarily renal, being almost equally 
divided between single methyl group xanthines and methyluric 
acids. Only 1 per cent remains unchanged (Axelrod and 
Reichenthal, 1953). While Cornish and Christman (1957) 
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reported that 48 hours are needed to clear 66 per cent of 
100mg caffeine dose, Axelrod and Reichenthal stated that 
there was no day-to-day accumulation of the drug after a 
500mg dose. The drug is fatal at doses of 3,000 to 10,000mg, 
if taken in a brief time span (Dimaio and Garriott, 1974). 
Cellular metabolic effects of caffeine include 
increases of muscle lactic acid, stimulation of oxygen 
consumption, and muscle twitches and contractures in high 
concentrations (Ritchie, 1970; Truitt, 1971). Miller et ala 
(1974) investigated the ability of caffeine to potentiate 
normal thermic responses and found that it caused a marked 
increase in oxygen consumption. These authors suggested that 
caffeine, by virtue of its negligible energy values and 
thermogenic properties, could be of value in weight-reducing 
regimes. 
Sutherland et ala (1968) provided a biochemical 
explanation for some of the metabolic and physiologic effects 
of the methylxanthines. The enzyme, phosphodiesterase, is 
necessary to convert cyclic 3' ,5' adenosine monophosphate to 
5' adenosine monophospate. Methylxanthines inhibit 
phosphodresterase breakdown of cyclic 3',5' adenosine 
monophosphate, which then prolongs its metabolic stimulating 
action in the cells. 
Toxicology 
Caffeine is considered a relatively safe drug; 
however, both accidental and intentional poisonings have 
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occurred. A five-year-01d girl died after ingesting 5,000mg 
caffeine alkaloid from her mother's bottle of over-the-
counter diuretic. In other cases, patients have 
unintentionally been given caffeine rather than their correct 
medications with fatal results (Dimaio and Garriott, 1974). 
Suicide has been reported due to caffeine ingestion. The 
individual intending to misuse it, however, is usually 
thwarted by another of its pharmoco1ogic properties, that of 
potent gastric irritation, which causes vomiting (A1sott et 
a1., 1973). 
The concentration of caffeine in postmortem blood has 
ranged from 80 g/m1 to over 1mg/m1. Untoward reaction, 
however, may be observed following the ingestion of 19 (15mg/ 
kg) or more of caffeine, leading to plasma concentrations 
above 30 ~g/m1. These are mainly referable to the CNS and 
circulatory systems. Insomnia, restlessness, and excitement 
are the early symptoms, which may progress to mild de1erium. 
Sensory disturbances such as ringing in the ears and flashes 
of light are common. The muscles become tense and tremulous. 
Tachycardia and extrasysto1es are frequent, and respiration 
is quickened (Dimaio and Garriott, 1974). 
Mutagenic Effects 
Caffeine induces chromosomal abnormalities both in 
plant cells and in mammalian cells in culture and has potent 
mutagenic effects on microorganisms either alone or in 
combination with other mutagens (Timson, 1977). These effects 
seem to be associated with inhibition of DNA repair 
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processes. The doses required to induce such inhibition, 
however, are significantly higher than those usually consumed 
by humans. Furthermore, available evidence suggests that 
caffeine is neither mutagenic by itself nor in combination 
with known mutagens in mammals. 
At very high doses, caffeine appears to have some 
teratogenic activity in mammals. One retrospective study 
(Weathersbee et al., 1977) indicated that pregnant women who 
ingest more than 600mg of caffeine per day in beverages may 
have an increased incidence of spontaneous abortion, still 
birth, or premature delivery. 
Kreybig and von Czok (1975) have analyzed other 
authors' data and the results of their own study of mutagenic 
and teratogenic effects of caffeine and soluble coffee in 
pregnant rats. Such effects were indeed observed after 
administration of high doses of caffeine - 240mg/kg (intra-
peritoneally) and 264mg/kg (orally) in rats, and 304 and 
4l0kg/mg respectively in mice. These doses greatly exceeded 
those usually taken by man, even in cases of coffee 
dependence. Taking this into account, normal coffee intake 
by pregnant women may be considered harmless unless it is 
proved injurous on other grounds. 
All the same, there are experimental data showing an 
effect of caffeine on cellular mitotic activity. Furmanova 
et ale (1976) have demonstrated that a caffeine concentration 
of 0.05336% suppresses the division of cells in Allium cepa 
L. root by 50%. 
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In the light of these data, the depressive action of 
caffeine on the division of cells requires further 
fnvestigation (Furmanova et al., 1976). 
other Illnes 
Caffeine in combination with 
aspirin, is widely employed in 
an analgesic, 
the ordinary 
.such 
types 
as 
of 
headache. There are few data to substantiate this use. 
Caffeine is also used in combination with an ergot alkaloid 
in the treatment of migraine. The ability of caffeine to 
produce constriction of cerebral blood vessels may improve 
the therapeutic response (RaIl, 1980). 
Because caffeine stimulates brain motor centres, it 
may be contraindicated for some epileptic patients. However, 
in some cases, the patient learns that drinking coffee 
relieves attacks. As an adjunct to diphenylhydantion, 
caffeine may be used to allay the drowsiness induced by the 
former; children and adults may be directed to drink a 
prescribed number of cups of coffee. Caffeine and herbs were 
the only treatment for narcolepsy until ephedrine sulphate 
was introduced in 1930 and amphetamine in 1935 (Lennox et 
al., 1960). 
After the claim that coffee could substitute for 
amphetamine or methylphenidate in the treatment of hyper-
kinetic behaviour in children (Schnockenberg, 1973), there 
have been a number of reports both confirming and denying the 
original observations {Reichard and Elder, 1977; Firestone et 
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al., 1978). However, these studies involved the use of 
single doses of caffeine unadjusted for body weight. 
A number of studies concerning caffeine, coffee, and 
cancer were reviewed in the British Medical Journal (1976). 
In animals, laboratory tests of caffeine for carcinogenicity 
gave essentially negative results. 
Caffeine, ascorbic acid, and sodium salicylate 
increase circulating serum levels of interferon in response 
to viral infection. Caffeine was the least active in 
elevating interferon levels (Geber et al., 1975). 
Caffeine has been withheld from patients with gout, 
due to the possibility that it could be converted into 
additional uric acid. Since the development of the uricase 
method of determining uric acid, all reported studies have 
indicated there is no increase in true uric acid secretion 
(Cornish and Christman, 1957). 
Statland et a1. (1976) reported on a male patient with 
diabetes, seizure disorder, a history of alcohol abuse, and 
liver disease who was hospitalized after complaints of severe 
abdominal pain for three days. His status deteriorated from 
alert to combative and finally to hepatic coma. Laboratory 
testing of his serum by gas-liquid chromatography revealed 
caffeine. A decrease in diphenylhydantion and witholding of 
caffeine and diazepam resolved the coma in 48 hours. The 
authors suggested the monitoring of caffeine levels in 
patients with comprised hepatic function who are also heavy 
coffee drinkers. 
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CAFFEINE EFFECTS ON PERFORMANCE 
The belief that caffeine enhances mental and physical 
performance is widespread and deeply embedded in our 
folklore, but experimental support for this belief is neither 
extensive nor unequivocal. 
One of the most comprehensive literature reviews of 
performance effects of caffeine was carried out by Weiss and 
Laties (1962). These investigators reviewed numerous early 
studies which had reorted performance enhancement with 
caffeine. Among them were improved ergonomic output on a 
bicycling task (Foltz, Ivy and Barborka, 1942), decreased 
reaction time (Cheney, 1935, 1936: Horst and Jenkins, 1935), 
increased tapping rate (Hollingworth, 1912: Lehman and Csank, 
1957), more accurate compensatory tracking (Seashore and Ivy, 
1953), greater galvanic skin response conditioned amplitudes 
(Switzer, 1935), and a slight increase in typing speed 
(Hollingworth, 19l2). However, caffeine has been found to 
disrupt or to produce no effect upon many of these variables 
(Adler, Burkhardt, Ivy and Arkinson, 1950: Hawk, 1929: 
Hollingworth, 1912: Hull, 1935). 
Thus, specific effects of the 
Weiss and Laties (1962) indicated some 
drug are not known. 
general conclusions 
without the benefit of analyses of treatment interactions: 
1. caffeine has little or no effect on reaction time 
2. caffeine impairs hand steadiness 
3. caffeine produces equivocal effects on motor co-ordination 
4. caffeine is capable of counteracting motor performance 
decrements produced by alcohol ingestion. 
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Fleishman and Bartlett (1969), who reviewed research on the 
effects of drugs on human performance, pointed out the need 
tor experimental studies evaluating the effects of specific 
drugs and dosage on specific classes of human performance. 
Caffeine has mixed effects with those in the 
workplace. Stimulation, increasing arousal, and anxiety do 
not necessarily result in improved performance. A summary of 
work in this area compiled by Truitt in 1971 includes: 
1. a prolonged and slightly increased ability to perform 
exhausting work, 
2. an unpredictable effect on simple and complex tasks 
involving choice and descrimination, 
3. tremor interference with hand steadiness, 
4. possible influences on eye-hand co-ordination, and 
5. improved mental activity in simple arithmetic, typing and 
uncoding. 
More recently caffeine has been shown to affect such 
variables as vigilance, accuracy, and reaction time. Sawyer 
et al. (1981) produced a summary of recent findings on 
caffeine and performance. This is illustrated in Table 5. 
Some endurance components are also included in Table 4 to 
compare caffeine's effects to those of epinephrine and 
norepinephrine on muscular contraction. 
One can extrapolate these simple tasks to more complex 
tasks in such situations as experimental work, industry, and 
daily living. As well as subject and work accuracy and 
efficiency being affected, individual differences occur and 
Table 5 
Summary of Recent Findings: Effects of 
Caffeine on Performance 
Performance Variable 
Physical endurance 
Bicycle ergometer 
Fixed load 
Progressive load 
Motor Skills 
Rapidity and accuracy 
Eye-hand co-ordinate 
Vigilance 
Visual 
Night-driving analogue 
Target scanning 
Low coffee users 
High coffee users 
Auditory 
Auditory 
Extroverts 
Introverts 
Reaction Time 
Regular reaction time 
Choice reaction time 
Decision time 
Motor time 
Verbal tests 
GRE practice test 
Speed and accuracy 
Extroverts 
Introverts 
Verbal test, time stress 
Accuracy 
Extroverts 
Introverts 
Verbal test 
Accuracy 
Low impulsives 
High impulsives 
From Sawyer et al., 1981. 
Effect of Caffeine 
+ (Costill et al., 1978) 
o (Perkins and Williams, 1975) 
- higher doses(paroli 1972) 
+ lower doses ' 
- (Putz-Anderson et al., 1981) 
+ (Baker and Theologus, 1972) 
o (Childs, 1978) 
+,0 (Clubley et al., 1974) 
+ o (Keister and McLaughlin, 1972) 
- (Paroli, 1972) 
+ (Smith et al., 1977) 
+ with increasing dosage 
First +, then -, with increasing 
dosage (Gilliland, 1977) 
+ (Revelle et al., 1976) 
+, AM: 
AM: 
- PM 
+ PM (Revelle et al., 1980) 
+, increases~ -, decreases~ 0, no change. 
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of caffeine are the results of direct stimulation, action 
through epinephrine, or indeed both, remains an unanswered 
question. 
Vigilance, Reaction Time, and Motor Skills 
The results of early investigations on caffeine 
effects on performance are conflicting. Payne and Hauty 
(1954) found the onset of fatigue slower after caffeine 20mg 
in a vigilance test. As early as 1912 Hollingworth reported 
that caffeine 300mg reduced reaction times. 
Gilliland and Nelson (1939) also found reaction times 
were reduced after one to two cups of coffee. Later in more 
controlled studies, Knowles (1963) and Franks et al. (1975) 
recorded reaction times after c feine 250 and 300mg/70kg, 
which were shortened but not significantly different from 
placebo. 
Clubley et al. (1978) obtained significant decrements 
in reaction time after caffeine 75-300mg but the observed 
decrement after caffeine 100mg did not differ significantly 
from that following the placebo. 
Since only the subjects varied between the two trials 
these results are probably indicative of considerable subject 
variation in sensitivity to caffeine, an observation 
previously made by Goldstein, Warren and Kaiser (1965). 
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there are interactive effects with personality variables. 
Changes which make work easier or more difficult may interact 
with arousal and anxiety levels to reduce or increase stress 
levels on the job. 
Caffeine has been reported to increase the capacity 
for muscular work (Ritchie, 1975). It has been argued that 
this is due to central nervous system stimulation, although 
peripheral effects cannot be discounted. Evidence for this 
effect comes from measurements and studies with the bicycle 
ergograph. 
However, both significant effects (Coste11 et a1., 
1978) at a fixed workload, and non significant effects 
(Perkins and Williams, 1975) using a progressive workload, in 
muscular work capacity have been reported. Factors such as 
the use of constant versus increasing workloads and/or the 
degree of physical fitness of subjects may be helpful in 
explaining the differing results of these two studies. 
Sawyer et a1. (1981) argued that one could hypothesize 
that these effects of caffeine on endurance are a combination 
of action of the central nervous system and action through 
sympathetic arousal. Furthermore, Inner and Nickerson (1970) 
reported that epinephrine facilitates neuromuscular 
transmission (ie. muscles contract for a weaker stimulus), 
increases the power of the contractions, and temporarily 
abolishes fatigue due to prolonged rapid stimulation of motor 
nerves. Ritchie (1975) reported that caffeine affects 
muscles in a similar manner. Therefore, whether the effects 
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Increased tapping rates after 324mg caffeine have been 
reported by Gilliland and Nelson (1939) Holck and Smith 
(l939), Lehman and Csonk (1957), but Flory and Gilbert 
(1943) found no effect after the same dose. Clubley et al. 
(1978) found tapping rates to be increased by caffeine doses 
of 150 and 300mg, but not 75 or 100mg. Tapping requires 
muscular work and since caffeine is known to strengthen and 
prolong the concentration of isolated skeletal muscle 
(Huidibro, 1945; Goffart and Ritchie, 1952) its effects on 
tapping may be due to a peripheral action. However, since 
these effects occur with doses also producing subjective 
arousal, peripheral effects and central stimulation cannot be 
separated. 
Subjective arousal after caffeine (150-300mg) has been 
reported (Barmack, 1940; Goldstein et al., 1965) although 
Knowles (1963) claimed no subjective effects occurred after 
250mg caffeine. 
Past research suggests that caffeine enhances 
performance in tasks requiring visual vigilance and seems to 
be especially effective in situations where vigilance 
normally becomes degraded due to boredom and fatigue (Baker 
and Theologus, 1972; Hauty and Payne, 1955; Regina et al., 
1974). Holland (1958) defines a vigilance task as a 
monotonous perceptual task which involves the monitoring of 
some infrequent but critical signs. Consequently, long-term 
performance of such monotonous tasks produces visual or task-
induced fatigue. 
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Regina et al. (1974) required subjects to drive an 
automobile for 90 minutes after consuming either 200mg of 
caffeine or a placebo. Following the initial drive, subjects 
ingested a supplemental dose (200mg) of either caffeine or 
placebo and continued the driving task for an additional 90 
minutes. Caffeine ingestion significantly decreased response 
times for acceleration, decelerations, and high beam signals. 
In an earlier study on a task analogous to night 
driving, Baker and Theologus (1972) found that, 1 hour after 
ingesting 200-400mg caffeine, alertness increased, ie. there 
were significantly fewer attention lapses. 
Lake and Meliska (1984) tested the effect of caffeine 
on a simple visual vigilance task under conditions designed 
to produce boredom and fatigue. Contrary to expectation, no 
improvement was found in vigilance as a result of caffeine 
ingestion compared to control. Thus, caffeine did not 
reverse a progressively deteriorating performance relative to 
control. 
Increases in motor performance were reported (Smith et 
al., 1977) in eight male university students on a choice 
reaction time task divided into two components: a decision 
component, ie. the time required to make a decision; and a 
motor component, ie. the time required to implement that 
decision. Following 200mg caffeine, decision scores were 
increased and motor scores were decreased. This illustrates 
how careful definition of the elements of a performance task 
is necessary to separate the specific effects of caffeine. 
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The regularity of caffeine consumption may also effect 
performance. Childs (1978) reported that 'high coffee users' 
responded significantly faster and more accurately in a 
visual scanning task than 'lower coffee users' when they 
ingested 400mg caffeine, but not when placebo or 200mg 
caffeine was ingested. 
Mental Tasks and Personality Variables 
Caffeine has been reported to show improvements in 
simple arithmetic and uncoding (Truitt, 1971), faster solving 
of maths problems (Paro1i, 1972), and adverse effects on the 
recall of a series of nonsense syllables (Hull, 1935). 
Studies involving more complicated mental tasks have 
shown an association between caffeine's effects and 
personality types. Eysenck's (1962) extraversion-intraversion 
model, predicted that the effects of a stimulant drug would 
be in an intraverting direction. In contrast, extraversion 
was associated with increased speed and decreased accuracy. 
Subjects in the caffeine studies have been divided into 
personality groups on the basis of Eysenck's theories. 
Table 6 shows some findings of studies involving 
caffeine effects and personality types. 
Sawyer et a1. (1981) point out that, while the 
division of subjects into extraverts and intraverts allows 
for the use of more sophisticated statistical tests, 
intraversion and extraversion are not manipulated and the 
Task 
Recording of digits 
GRE practice test 
Verbal ability test 
under stress 
Table 6 
Caffeine Effects and Personality Types 
Condition 
(mg Caffeine) 
o mg 
200 mg 
Increasing dosages 
200mg caffeine 
plus time stress 
Personality Group Performance 
Extroverts 
Decrease 
No decline 
Increase 
Increase 
Introverts 
No change 
NO decline 
Increase then 
decrease 
Decrease 
Researchers 
Keister and McLaughlin, 1972 
Extroverts performed like introverts 
thr9ugh increased persistence and 
accuracy, in acord with Eysenck's theory 
of the interaction of stimulants and 
personality types. 
Gilliland, 1980 
This suggests a limit to the beneficial 
introverting effects obtained through 
caffeine. 
Revelle et al., 1976 
This suggests that while caffeine may 
help extroverts perform on this task, 
the performance of introverts is 
impaired under high levels of caffeine 
or added stress. 
tf::o, 
00 
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results show an association among personality variables, 
caffeine, and performance, but not causality. However, one 
wonders if manipulation of intraversion and extraversion 
would ever be possible. 
CAFFEINISM 
Caffeinism, a diagnosis recently included in the third 
edition of the American Psychiatric Associations Diagnostic 
and Statistical Manual of Mental Disorders (DSM-III), is 
characterized by a constellation of affective, sleep, and 
psychophysiological manifestations. Caffeinism can be 
pharmacologically defined as the ingestion and consequent 
actions of high doses of caffeine, whether from tea, coffee, 
cola drinks, over the counter substances, or prescription 
medications. 
Symptoms of caffeinism are best understood as dose-
related extensions of caffeine's expected pharmacological 
actions (Greden, 1974). The main symptomatic areas involve, 
1. anxiety manifestions, 2. depression, 3. tolerance, 4. 
withdrawal symptoms, 5. Restless Legs syndrome. 
Anxiety Manifestations 
Several clinical reports have suggested a link between 
caffeine consumption and anxiety in psychiatric patients 
(Greden, 1974; Furlong, 1975~ Winstead, 1976; Greden et al., 
1978~ Stillner et al., 1978; Mikkelsen, 1978). 
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Greden et al. (1978) found that psychiatric inpatients 
estimates of prehospitalization caffeine consumption were 
riorrelated with anxiety, depression, and the use of sedative 
hypnotics and minor tranquilizers. In another report Greden 
(1974) concluded that for three patients, excessive caffeine 
consumption produced anxiety symptoms indistinguishable from 
anxiety neurosis. Greden (1974) and Furlong (1975) reported 
the symptoms of caffeinism to be nervousness, tremulousness, 
muscle twitching, insomnia, sensory disturbances, 
palpitations, flushing, arrythmias, diuresis, and periods of 
anxiety, agitation and depression. 
Anxiety and some of the other symptoms of caffeinism 
were listed by Innes and Nickerson (1975) as side effects of 
both epinephrine and norepinephrine injections (see Table 4). 
Sawyer et al. (1981) pointed out that since caffeine 
increases the levels of these hormones it is not clear 
whether one or all of these agents is the precipitating 
factor in the resulting anxiety. Furthermore, they added 
that these may interact with situational variables so that 
subclinical levels of anxiety increase to clinical levels. 
In two of the three case studies given by Greden (1974), 
situational sources of anxiety were clearly present. 
Significantly higher trait anxiety and depression 
scores were obtained for moderate (one to five cups per day) 
to high (five or more cups per day) coffee consumers in a 
study to determine the relationship between regular coffee 
consumption and the incidence of caffeinism in a non-clinical 
population (Gilliland and Andress, 1981). These anxiety 
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levels were subclinical, but the authors suggest that they 
may indicate significant and stressful differences in such 
factors as sleep patterns and nervousness. The high 
consumers also reported significantly higher levels of 
caffeinism symptoms, higher frequencies of psychophysio-
logical disorders and lower academic performances. 
Depression 
Periods of depression and agitation were listed by 
Greden (1974) among the symptoms of caffeinism. Ritchie 
(1975) states, "There is no doubt that excitation of the 
central nervous system produced by large amounts of caffeine 
is followed by depression." 
A number of psychiatric studies (Furlong, 1975; Greden 
et al., 1978; Neil et al., 1978) and non clinical studies 
(Gilliland and Andress, 1981), reported a higher incidence of 
depression among high caffeine consumers, than with low users 
and abstainers. These suthors suggested that self-medication 
with caffeine could be an attempt to alleviate the anergia 
and hypersomnia experienced during certain. types of 
depression. Neil et ale (1978) warned that excessive use of 
caffeine in this manner can "lead to diagnostic confusion and 
complicate pharmacotherapy". Al though Bowen et al. (1981) 
found that caffeine does not precipitate or otherwise lower 
the amounts of circulating antipsychotic drugs, the 
possibility of competitive interactions between caffeine and 
these drugs still remains. 
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More recently research by Veleber and Templer (1984) 
involved a double blind experiment which controlled for body 
w'eight and usual consumption using three dosage levels, Omg, 
150mg or 300mg caffeine, with normal subjects. The subjects 
were twice administered the Multiple Affect Adjective 
checklist (MAACi Zuckermin, Lubin, Vogel and Valerious, 1964) 
which has three scales assessing current anxiety, depression 
and hostility. Caffeine was found to increase anxiety, 
depression and hostility. 
Finding a positive 
scores and caffeine dosage 
relationship between postanxiety 
was expected because of the 
previous literature and caffeine's known pharmacological 
actions. However, the positive relationship between post 
depression scores and caffeine dosage was less predictable. 
Although popular belief holds that caffeine raises mood, it 
is widely recognized that other central nervous stimulants, 
such as amphetamines and cocaine, produce depression 
following an initial mood elevation. Veleber and Templer 
(1984) believe that the positive relationship in depression 
found in their study may be due to time-after-consumption 
parameters. That is, if the posttest MAAC had been 
administered sooner, a posi ti ve relatio'nship may not have 
been found. 
The authors suggested that future research that 
delineates for whom caffeine is harmful should explore such 
time-after-consumption parameters. 
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Tolerance 
An acquired tolerance to two actions of caffeine has 
been demonstrated unequivocally in man, namely diuresis (Eddy 
and Downs, 1928) and parotid gland secretion (Winsor and 
Strongin, 1933). These examples of tolerance were recognized 
by the responses to the ingestion of caffeine in coffee or 
water before and during the chronic consumption of 
caffeinated beverages. 
The sleep-disturbing properties of caffeine are 
clearly more marked among non-users than among habitual users 
of coffee (Goldstein, 1964a). Differences were also noted in 
the extent to which caffeine disturbed the soundness of 
sleep. Subjects who were heavy coffee drinkers tended to 
report sleeping more soundly on placebo nights. In another 
investigation, Goldstein (1964b) established that 150 to 
200mg caffeine taken shortly before bedtime prolonged the 
time required to fall asleep, although the effect was less 
pronounced in heavy caffeine drinkers. 
Colton et al. (1968) also reported that sensitivity to 
caffeine was greater in non-coffee drinkers who 
disturbed sleep patterns, particularly delayed 
sleep. Coffee drinkers were relatively insensitive 
actions of caffeine. 
reported 
onset of 
to the 
It has been suggested that tolerance may develop to 
the mood-altering properties of caffeine, such as nervousness 
and anxiety. However, extensive reviews of the pharmacologic 
54 
actions of this alkaloid (Eichler, 1938) and the psycholgical 
and behavioural effects of caffeine (Weiss and Laties, 1962), 
made little mention of tolerance. Indeed, Greden (1974) 
reported that individuals with caffeinism can be recognized 
by their chronic anxiety. 
Studies have indicated that as little as 500mg (about 
five cups of coffee) ingested daily can result in the 
development of tolerance and of habituation, leading to a 
gradual increase of daily consumption (Goldstein, 1964; 
Colton et al., 1968; Goldstein and Kaizer, 1969; Greden, 
1980). As one can imagine, chronic ingestion of caffeine, 
with daily intakes of ten or more cups of coffee per day, may 
develop into a routine ritual. However, if such a dose was 
ingested by a non coffee drinker, then one would 
clinical and pharmacological consequences to 
apparent. 
Caffeine Withdrawal Symptoms 
expect the 
be readily 
The development of caffeine-withdrawl headache is well 
document~d (Dreisbach and Pfeiffer, 1943: Miller, 1960; 
Goldsteon and Kaizer, 1969). Dreisbach and Pfeiffer (1943) 
described the typical reaction. Headaches as extreme in 
severity as the subjects had ever experienced were produced 
by the sudden withdrawal of caffeine. The subjects were 
unaware that the capsules had been switched to placebos. The 
headache which developed was slow in onset, central in 
origin, became generalized after 4 to 6 hours, and was 
sometimes accompanied by nausea and vomiting. Blood chemistry 
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studies indicated serum calcium fell and serum phosphorus 
rose. Goldstein and Kaizer (1969), reported on caffeine 
withdrawal in a group of housewives in the natural setting of 
their homes. Moderate to heavy coffee drinkers described a 
special set of reactions in additions to headache~ 
irritability, inability to work effectively, nervousness, 
restlessness, and lethargy. Three elements associated with 
caffeine withdrawal headache by Greden et al. (1978) are 
regular consumption of 500mg caffeine per day, development of 
tolerance, and sudden abrogation of caffeine intake. 
Headache may occur simply from excessive use of 
caffeine. Some patients with recurring headaches resort to 
caffeine-containing analgesics. As the time from the last 
intake increases, the likelihood of headache also increases. 
Taking caffeine relieves the headache only temporarily and 
thus sets up a vicious cycle of recurring headaches (Selbach, 
1973; Miller, 1960). 
Hypertensive headache has been relieved by intravenous 
administration of caffeine. Selbach (1973) suggests that 
constriction of cerebral arteries decreases the brain 
swelling caused by hypertension. Caffeine administration 
during the first or prodromal phase of the four phases of 
migraine headache blocked further headache development in 
some individuals (Selbach, 1973). 
In an ongoing investigation of caffeinism, Greden et 
al. (1980) used a questionnaire to determine whether there is 
a constellation of psychiatric characteristics associated 
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with this type of headache. They found that persons who are 
susceptible to the syndrome generally report more symptoms of 
anxiety and depression and rate higher in tests evaluating 
those parameters; consume more antianxiety agents; feel they 
are less healthy: and have a significantly higher caffeine 
intake that persons without caffeine-withdrawal headaches. 
Coupling these findings with those reported by 
Dreisbach (1943) and Goldstein (1969), Greden et al. (1980) 
concluded that the caffeine-withdrawl headache does exist as 
a clinical psychiatric syndrome. 
In a subjective evaluation of the symptoms of caffeine 
withdrawl (Roller, 1981), a 40-year-old healthy male (90kg) 
who regularly drank 900-ll00mg caffeine daily, abstained from 
coffee for 72 hours. Headache started 6 hours later, 
followed by tiredness and lassitude, rhinnorrhea, leg pains, 
and diaphoresis and, later still, general muscle pains as 
with influenza. When the subject resumed coffee drinking, 
all symptoms were alleviated within 3 hours. Roller urged 
further studies to confirm the presence of these symptoms in 
others, to quantify these effects, and to determine the role 
of these effects in caffeine usage. 
Caffeine withdrawal programs will precipitate 
withdrawal symptoms including anxiety. White et al. (1980), 
found that regular consumers of caffeine had higher muscle 
tension after three or more hours of abstinence than low 
caffeine consumers. This difference was absent after double-
blind administration of caffeine citrate or placebo. Among 
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subjects receiving 
with prior caffeine 
placebo, anxiety 
use, suggesting 
was highly correlated 
that even a brief 
withdrawal may produce anxiety in the regular user. 
Restless Legs Syndrome 
Lutz (1978) on 
with 62 patients over an 
caffeine is the major 
the basis of therapeutic experience 
11 year period, concluded that 
factor in the causation of the 
'restless legs syndrome'. Other clinical, constitutional-
hereditary (ie. "neurotic") and environmental (eg. sedentary 
occupation, exercise deprivation) factors, including 
seasonally heightened or stress-related autonomic arousal may 
enter the clinical picture in varying degrees and modify the 
individual sensitivity to caffeine. 
The main symptom of restless legs consists of 
unpleasant creeping sensations in the lower legs, between the 
knee and ankle. Many patients experience simultaneous 
restlessness in their arms, shoulders, nuchal and pectoral 
muscles although the flexor muscles of legs, arms and 
sometimes thighs with their greater muscle bulk are preferred 
sites. The creeping sensations are usually localized deep in 
the extremities into the muscles or bones, but most patients 
have difficulty in precisely localizing their discomfort. 
The discomfort appears only at rest and elicits on 
irresistable need to move their limbs. It generally appears 
in the evening and early night and may be associated with 
severe insomnia. The unpleasant sensation is usually 
described as having a crawling, restless or aching quality. 
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Caffeine is responsible for the increased nervous 
system arousal (cortex, medulla, spinal cord) as well as for 
the direct peripheral contractile effect on the striated 
muscle. Lutz (1978) believes that the increased striated 
muscle contractility interfers with the microcirculation to 
sensory nerve endings, leading to increased irritability of 
these structures, responsible for the dysphoric sensation of 
muscular restlessness. This sensation could also be viewed 
as a toxic sensory disturbance. Toxic sensory manifestations 
(eg. hypersthesias) are known to occur with caffeinism. 
The nocturnal preference of restless legs can be 
explained on the basis of increasing central nervous system 
excitation as the day goes on and relative sensory isolation 
at night which leads to increased proprioceptive awareness. 
Treatment consists of the elimination of caffeine-
containing beverages, food and medications (often used to 
counteract the restless leg syndrome) and the temporary 
administration of diazepam with its central sedative and 
peripheral muscle relaxing effect. 
PROBLEMS INVOLVED WITH RESEARCH INTO 
THE EFFECTS OF CAFFEINE 
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1. Most of the reported effects have been clinically observed 
or inferred from survey data, and there has been very 
little experimental research. As a result, there is little 
evidence for a causal link between the wide range of 
reported effects and caffeine intake. 
2. The small subject samples evident in the experimental, 
survey and clinical data, tend to reduce reliability of 
the reports of caffeine effects. 
3. Caffeine has a number of physiological effects. These 
effects are considered to be transient, returning to base-
line levels as caffeine is depleted from the system. 
Studies in this area have been done using healthy subjects 
who have typically abstained from caffeine for a period of 
time prior to the experiments. In fact, the systems of 
people who drink coffee regularly during the day and 
evening may never be completely clear of caffeine. 
The effects of this kind of constant stimulation have not 
been studied at all (Sawyer et al., 1981). Nor have 
experiments been done on chronically ill persons whose 
physiological levels are already abnormal, so it is not 
certain what kinds of changes caffeine will induce in 
these areas. 
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4. The literature on the cardiovascular and autonomic effects 
of caffeine in man includes few double-blind studies, and 
even these reports have generally failed to separate 
adequately the truly caffeine-naive subjects from the 
population of coffee drinkers. Even some double-blind 
studies that include "coffee drinker" and "non-coffee 
drinker" categorizations define the non-coffee drinker in 
such a way that a person ingesting 85mg of caffeine (1 cup 
of coffee) daily would qualify as a "non-coffee drinker" 
(Colton et al., 1968). 
The identification of truly caffeine-naive subjects for 
study may be important, since tolerance clearly develops 
to such effects of caffeine as diuresis (Eddy and Downs, 
1928), parotoid-gland secretion (Winsor and Strongin, 
1933), bradycardia and sleep disturbance (Colton et al., 
1968). 
It seems likely that the physiological effects of single 
doses of caffeine could be underestimated if subjects had 
not totally abstained from caffeine in the period before 
study. Furthermore, in studies on catecholamine output 
after caffeine, the dietary intake of sodium has rarely 
been controlled, though dietary sodium has a definite 
effect on urinary and plasma 
(Robertson et al., 1977). 
catecholamine levels 
5. Many researchers have failed to note and take account of 
their subjects' histories of caffeine intake. This is 
very important when considering that tolerance to caffeine 
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does exist and there is variability to some effects of 
caffeine and not to others. 
6. A basic problem in 
people are unaware 
gathering information is that many 
of the amount of caffeine that they 
actually ingest. Beyond their coffee and tea consumption 
they are not aware that caffeine is present in many other 
common substances. 
7. Laboratory findings are often limited by their question-
able transfer to events outside the laboratory setting. On 
the other hand, attempts to study phenomena in natural 
settings often sacrifice manipulative control and 
precision of measurement. 
CHAPTER THREE 
THE EXPERIMENT 
INTRODUCTION 
Caffeine has physiological effects which are similar 
to those observed in association with psychological or 
psychosocial "stress". Both caffeine and acute psychological 
stress will produce elevations in plasma epinephrine and 
norepinephrine paralleled by elevations in blood pressure and 
heart rate, in addition to their other effects (Kanzett, 
1975; Rose, 1980; Mason, 1975; Ritchie, 1975; Robertson et 
al., 1978). 
The similarity of these two patterns of cardiovascular 
and hormonal responses suggests the possibility that stress 
and caffeine could interact or, more specifically, that 
caffeine may intensify the cardiovascular and hormonal 
effects produced by stress. The pathogenesis of both 
coronary artery disease and hypertension 
thought to be significantly influenced by the 
effects of psychological stress (Taggart 
1981). 
are currently 
physiological 
and Carruthers, 
Because caffeine consumption and stress are both 
common features of contemporary life, a caffeine-related 
potentiation of these harmful e ects of stress could have 
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especially important implications for the 
cardiovascular disease. Psychologically, 
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development of 
the potential 
additive effect of caffeine on stress could have an effect on 
one's performance when encountering a stressful situation, 
ego exams or public speaking. 
The hypothesis that caffeine can intensify responses 
to stress is supported by the work of three main studies in 
this area (Cobb, 1974; Henry and Stephens, 1980; Lane, 1983). 
Cobb (1974) carried out a long term study of 
automobile factory workers. The subjects studied came from 
two companies that closed at the end of 1965 and 1966, 
respectively, and from four companies for which there was no 
threat of termination. The terminees were visited during the 
phase of anticipation, shortly after the closing, and 6, 12 
and 24 months later. At each visit to the subject's home, a 
standardized set of physiological, psychological, social and 
economic data were collected by public health nurses. The 
controls were visited at similar intervals except that very 
few were followed beyond 12 months. The two groups of 100 
terminess and 74 controls were virtually homogenous over 43 
variables including, academic level, wages, age, and marital 
status. 
Cobb found that the mean rate of norepinephrine 
excretion was significantly elevated for those whose jobs 
ended, before termination and for twelve months afterwards. 
Of particular interest however, was the finding that when 
automobile workers consumed coffee during the time of 
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anticipation and of termination, their increase in norepine-
phrine output was significantly greater than that of non-
coffee-drinking workers who lost their jobs. 
Figure 1 illustrates the physiological changes in men 
whose jobs were termninated. The effect 
consumption is also shown. 
Figure 1 
Physiological changes in men whose 
jobs were terminated 
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Norepinephrine excretion rate by phase and by whether or not coffee was 
taken. From Cobb (1974). 
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There was no coffee effect at all among those who were 
in no danger of losing their jobs and for all of the 
terminees at 24 months, but for the stressful period of 
anticipation plus termination there was a highly significant 
difference and for 6 and 12 months later, there was a slight, 
non-significant difference. 
Cobb's research demonstrates the importance of 
considering interactions with the environment when looking at 
physiological processes. He explains his findings by 
suggesting the possibility that caffeine intake at stressful 
times, could accentuate, perhaps to a critical point, a 
neurotransmitter response cycle that enhances already-
developing clinical symptoms. 
Henry and Stephens (1980) investigated caffeine as an 
intensifier of stress-induced hormonal and pathophysiologic 
changes in mice. They demonstrated that the substitution of 
coffee for drinking water produced greatly increased rates of 
disease and mortality in mice living in large community 
cages, where stressful, competitive interaction typically led 
to cardiovascular and renal pathology. Caffeine-related 
enhancements of these effects 
stimulation included increases in 
of competitive social 
blood pressure, adrenal 
weight, and plasma renin and corticosterone. Caffeine 
produced similar results, although to a lesser degree, in 
mice whose environment was less stressful. The authors 
concluded from the study that caffeine can indeed intensify 
responses to stress. 
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This finding is reminiscent of Henry's (1969, 1970) 
observation of hypertension in mice. Isolated mice had 
iittle or no rise in blood pressure when given coffee rather 
than water; while those mice boxed in groups of eight so they 
had the opportunity to fight, had significantly greater rises 
if they were on coffee. 
More recently Lane (1983), examined the potential 
interaction of caffeine and psychological stress in 10 
"caffeine-naive" human subjects. The cardiovascular effects 
of a moderate dose of caffeine (250mg), equivalent to two or 
three cups of coffee, were measured during periods of rest 
and psychological stress. Comparisons of caffeine and 
placebo were made with regard to levels of cardiovascular 
activity during rest and stress 
cardiovascular response elicited 
and 
by 
to the magnitude of 
the psychological 
stressor. Moderate doses of caffeine were found to show 
elevations in blood pressure (both systolic and diastolic) 
during periods of rest and stress. Blood pressure during 
stress was also significantly higher after caffeine had been 
consumed. 
Figure 2 shows the effects of caffeine on systolic and 
diastolic blood pressure at rest and during psychological 
stress. 
Lane (1983) concluded from his findings 
elevation of blood pressure due to caffeine appeared 
to that elicited by stress. 
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The elevation in systolic and diastolic blood pressure 
produced by caffeine was significant (p<O.05) for the Post-
drug rest, Stress, and Recovery periods. The effect of 
caffeine was equivalent at each of these three points. 
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NATURE AND SCOPE OF THE EXPERIMENT 
The present study examined the potential interaction 
of caffeine and psychological stress in human subjects who 
regularly consumed caffeine. More specifically subjects 
comprised of those who showed 'high' and 'low' anxiety levels 
as determined by administration of the Spielberger Trait 
Anxiety Inventory, and consumed 2 or more cups of coffee 
and/or tea per day. 
The cardiovascular effects of a high (400mg) dose of 
to 4 or5 cups of coffee were measured 
rest and psychological stress. The 
caffeine, equivalent 
during periods of 
magnitude of the effect of caffeine on blood pressure and 
(resting) and during stress was made. heart rate before 
Subjective ratings of alertness and tension were recorded 
respectively after each part of the experiment and scored 
from the visual analogue scales yielding numbers from a to 
100. Comparisons of performance in a mental arthimetic task 
(stressor) between caffeine and a placebo were made, as well 
as a determination of any significant effects between 
subjects with high anxiety levels and those with low anxiety 
levels. 
Aims of the Experiment 
1. To measure any subsequent changes in physiological 
responses to caffeine in blood pressure (systolic and 
diastolic), during rest and stressful situations. 
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2. To measure.the effects of caffeine upon psychological 
performance during a stressful situation, ie. does 
caffeine impair of enhance performance? 
3. To measure self reported "alertness" and "tension" 
following caffeine consumption, ie. is caffeine associated 
with greater or less reported alertness and tension during 
a stressful task than during a resting period? 
4. To determine whether caffeine shows any additive effect on 
the cardiovascular measurements and subjective self 
reports, with that produced by psychological stress. 
5. To determine whether any significant differences in 1, 2, 
3, and 4 exist between subjects with high trait anxiety 
levels and those with low trait anxiety levels. 
Rationale and Hypotheses of the Experiment 
Previous investigations have highlighted the 
importance of the inverted-U relationship between the amount 
of stress induced by the task and performance efficiency 
(Yerkes and Dodson, 1908). According to the inverted-U 
hypothesis, task performance is optimal at intermediate 
levels of task difficulty or stress (drive level) and poor 
when drive level is either low enough to cause boredom or too 
high causing task interference (Broadhurst, 1959; Hebb, 1955; 
Malmo, 1959). 
Anxiety levels then, can increase or decrease 
performance. If one is too anxious one tends not to do so 
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well, as is the case if one were not at all anxious. 
However, at intermediate levels of anxiety optimal 
performance may be obtained. 
Although past research has looked at the effects of 
caffeine on anxiety and stress among regular and non-regular 
consumers, I am unaware of any studies regarding comparisons 
of the effects of caffeine on those in the population who 
have generally high trait anxiety levels and those who have 
generally low anxiety levels. 
Caffeine consumption has been shown to increase 
arousal and awareness levels due to its central nervous 
system stimulant properties (Thompson, 1975; Ritchie, 1975; 
Graham, 1978). 
I have addressed the relationship between caffeine 
consumption, level of anxiety (Trait High vs Low), and 
performance efficiency in a study of mental arithmetic 
(Stressor), to test the hypothesis that: 
Caffeine consumption might be used as a means for a 
low anxiety person to reach an optimal level of 
anxiety in order to perform well in a stressful 
situation ego exams or speech. Likewise, caffeine 
consumption may well be avoided by those who have 
high anxiety levels if they are to perform well 
under psychological stress. 
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PROCEDURE 
Subjects 
Thirty-eight volunteer stage one Psychology students 
comprising 23 females and .15 males participated in the 
experiment. The ages ranged from 17 to 40 years with a mean 
age of 22. 
The subjects were screened for testing in the 
experiment according to the following criteria: 
- They regularly consumed caffeine, ie. drinking at least 
2 or more cups of coffee and/or tea per day. 
- They obtained scores which were at the extremes of the 
Spielberger Trait - Anxiety Inventory, ie. High anxiety 
subjects and Low anxiety sUbjects. 
Apparatus 
The experiment was carried out in a controlled 
laboratory setting. Noise was kept to a minimum, and the 
subject sat on a chair beside a desk for the entire session. 
a) Physiological measurements 
Blood pressure. An electronic 3005 blood pressure 
meter was used to record subject's systolic and diastolic 
blood pressure in mm Hg. 
Heart rate. The digital heart rate monitor (Model 
77065), electronically measured heart rate in beats per 
minute (BPM) to within an accuracy of ±l BPM. 
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b) Performance measurements 
A set of 2 figure and 3 figure subtraction problems 
(devised by the author) was used in the serial subtraction 
mental arithmetic task which provided the stressor in the 
experiment, ego (14-9, 219-102, 911-712). The same set was 
administered to all subjects, on both testing sessions. 
A standard tape recorder was used to record the 
student's responses to the mental arithmetic task. Results 
were later audited to determine performance. 
c) Subjective reports 
Reports of sUbjective "Tension" and "Alertness" were 
taken at certain intervals during the experiment, using 
Visual Analogue Scales (VAS). Each of these involved a 
horizontal line 10cm long with a statement at one end that 
the symptom, feeling or attitude could not be stronger and at 
the other that it was completely absent. After being made to 
understand what it was meant to signify, subjects made a mark 
somewhere along its length to indicate their impression of 
the strength of that feeling. Measurement to the nearest mm 
provided a sufficiently large number of categories to allow 
considering it as a continuum, and so the scores met 
assumptions necessary for parametric analyses. 
A digital stopwatch was used for timing throughout the 
experiment. 
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d) Trait Anxiety Inventory 
To assign subjects to either the High anxiety group or 
the Low anxiety group the Spielberger Trait Anxiey Inventory 
(Spielberger, 1970) was administered. Instructions to the 
subject indicated that the given scale ("Trait") anxiety 
referred to the subject's habitual mode or feeling. 
The "A-trait scale" comprises 20 statements which 
refer to how the subject generally feels. Each statement 
(eg. "I lack self-confidence") is rated on a 4 point scale 
from "almost never" to "almost a1ways". 
e) Drugs 
Caffeine. The caffeinated drinks contained caffeine BP 
(white powder form). The drink consisted of 400mg caffeine 
mixed in 48m1s of water and 2m1s of "Thriftee" diabetic drink 
concentrate to lower the bitterness and make more palatable. 
Placebo. Placebo drinks contained quinine sulphate as 
it provided sufficient bitterness to mimick the taste of 
caffeine. As this component is pharmacologically inactive at 
doses of or below Smg/SOm1, the drink consisted of Smg 
quinine sulphate mixed in 48m1s of water and 2m1s of 
"Thriftee" diabetic drink concentrate. 
Method 
Two hundred stage one Psychology students who 
regularly consumed caffeine (2 or more cups of coffee and/or 
tea per day) completed a self-evaluation questionnaire 
(Spielberger Trait Anxiety Inventory). The sample population 
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in the experiment comprised those who obtained scores at 
either extreme of the scale, ie. High and Low anxiety scores. 
Criterion for assignment to High and Low Anxiety groups 
As about 40 subjects were required for any valid and 
reliable representation, the following criterion was used as 
a means of assigning roughly equal numbers to the 
experimental groups. 
High Anxiety group. Comprised subjects who scored 51 
and above on the Trait Anxiety Inventory. N=22. (ie. top 11% 
of scores) 
Low Anxiety group. Comprised subjects who scored 36 
and below on the Trait Anxiety Inventory. N=20. (ie. bottom 
10% of scores) 
Subjects who scored between 36 and 51 were excluded 
from the experiment. 
Although initially 42 subjects agreed to participate 
in the experiment only 38 completed both sessions. 
The subjects who failed to complete the experiment 
(all females) were not able to cope with the stressor (mental 
arithmetic task), becoming very anxious, agitated, nervous, 
noticably shaking - 3 even to the point of crying. The other 
female subject who failed to complete both sessions, had a 
history of epilepsy. During the mental arithmetic task she 
began to show symptoms of the initial stages of an epileptic 
seizure, ie. shaking, crying, involuntary spasms in her arms. 
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Although perhaps being an unfortunate consequence of 
the experiment, the behaviour of these four subjects did 
serve an indirectly useful purpose, indicating that the 
mental arithmetic task was indeed a potent stressor. 
Subjects were briefed prior to the experiment about 
location, time etc. and were asked to refrain from drinking 
any caffeine (coffee, tea, cocoa, cola, chocolate) on the day 
of the experiment). 
Each subject was individually dealt with. An initial 
15 minute Predrug resting baseline was taken while the 
subject sat quietly. Both heart rate (HR) and blood pressure 
(systolic, SBP, and Diastolic, DBP) measurements were taken 
at 3 minute intervals. This provided a measure of cardio-
vascular activity for later comparisons. At the end of this 
Predrug resting period, the subject was administered two 
visual analogue scales - a "Tension" scale and an "Alertness" 
scale for completion. 
Caffeine or the placebo was then administered using a 
single-blind procedure. The subject drank either 50ml of 
cordial containing 400mg of caffeine, or the 50ml of cordial 
containing the placebo quinine sulphate. The order of 
administration was random for each subject, but counter-
balanced such that half of the subjects received caffeine 
first and the other half placebo first. Each subject then 
relaxed for 30 minutes and read magazines. This allowed 
sufficient time for plasma caffeine levels to reach near 
maximum (Robertson et al., 1978). 
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Following this, measurements of heart rate and blood 
pressure were taken every 3 minutes during a 15 minute Post-
drug resting baseline interval while the subject sat 
quietly. At the end of this Postdrug resting period, 
subjects completed the "Tension" and "Alertness" visual 
analogue scales. 
After this second resting baseline, instructions were 
given for the psychological stressor, namely performance on a 
serial subtraction mental arithmetic task under challenging 
conditions. Instructions read; 
"You are now going to be·given a mental·arithmetic 
task. You have exactly two six minute periods to 
subtract as quickly as possible without making 
errors. 
Being at the stage one level you should be able to 
answer everyone correctly with no mistakes. 
will be tape recorded for later 
comparison with other stage one 
results will be posted on the stage 
Your answers 
analysis, as a 
students, and 
one noticeboard next term. 
Give one answer only even if you think you've made 
a mistake and do not work out aloud. You must have 
an answer for each question. 
Remember to go as quickly and as well as you can in 
a loud clear voice. 
Any Questions?" 
Tasks of this type are known to produce elevations in heart 
rate and blood pressure, as well as elevations in plasma 
epinephrine, norepinephrine, prolactin and cortisol (Lane, 
1983). 
Subjects performed this task continuously for two six 
minute periods with a 15 minute "stress" interval while heart 
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rate and blood pressure were measured every 3 minutes. At 
the end of this IIstress" period subjects completed "Tension" 
~nd "Alertness ll visual analogue scales. 
The final 15 minute Recovery period involved the 
subject again sitting quietly while cardiovascular activity 
(heart rate and blood pressure) was assessed every 3 minutes. 
"Tension" and "Alertness II scales were also administered. 
The second session for each subject was identical to 
the first with the exception the drug condition. Heart 
rate, systolic blood pressure, and diastolic blood pressure 
were averaged separately for each of the four periods in each 
experimental session. The tape recordings of the mental 
arithmetic task performances were audited and the total 
number attempted and percentage correct determined. The 
subjective ratings of "alertness" and "tension", recorded 
retrospectively after each part of both sessions were scored 
from visual analogue scales yielding numbers from a to 100. 
CHAPTER FOUR 
RESULTS 
The effects of caffeine were analysed with respect to 
the following experimental variables: 
A: Trait anxiety level (high or low) 
B: Sex (male or female) 
c: Order of drug condition presentation 
ie. caffeine (1st) + placebo (2nd) 
or 
placebo (1st) + caffeine (2nd) 
D: Drug condition (caffeine or placebo) 
Results were reported under three main headings; 
1. Physiological measures 
- systolic blood pressure (SBP) 
- diastolic blood pressure(DBP) 
- heart rate (HR) 
2. Subjective report measures 
- tension 
- alertness 
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3. Performance measures 
- total attempted in mental arithmetic task 
- percentage correct in mental arithmetic task 
Calculations 
Calculations involved four way ANOVA's (A, B, C, D 
repeated on D, unequal groups). In view of the large number 
of analyses, the null hypothesis was only rejected at p<.Ol. 
Three groups of ANOVA's were performed, ie. 
1. Predrug ANOVA's 
ANOVAs were performed at the predrug level of each of 
the physiological and subjective report measures to determine 
if any significant differences existed before drug 
administration. 
2. ANOVA's on three difference scores 
As the main emphasis of the experiment focused on the 
significant changes each measure (SBP, DBP, HR, tension and 
alertness) could undergo between the four periods of the 
experiment, results were reported as: 
x = Eostdrug: value - Eredrug: value 
postdrug value + predrug value 
y = stressor value - Eostdrug: value 
stressor value +,postdrug value 
z = recovery value - stressor value 
recovery value + stressor value 
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Example: Predrug - Postdrug SBP (x): 
Predrug SBP value = 115 mm Hg, Postdrug SBP value = 127 mm Hg 
x = postdrug value-predrug value = 
postdrug value+predrug value = 
3. Performance ANOVA's 
127-115 = 
127+115 = 
12 
242 = .05 mm Hg 
separate ANOVA's were carried out on the performance 
scores calculated as: 
a) Total attempted 
b) Percent correct 
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PREDRUG DATA 
The following tables represent the mean values 
obtained for each measure in each group at the predrug level 
of the experiment. 
Physiological Measures 
Table 7 
Predrug systolic blood pressure (SBP) mmHg 
Sex Anxiety Order of drug presentation Caffeine Placebo 
level condition condition 
High Caffeine 1st ... Placebo 2nd 121.5 126.3 
Male Low Caffeine 1st ... Placebo 2nd 119.3 120.8 High Placebo 1st ... Caffeine 2nd 125.2 135.5 
Low Placebo 1st ... Caffeine 2nd 125.4 126.9 
High Caffeine 1st ... Placebo 2nd 112.7 116.8 
Female Low Caffeine 1st ... Placebo 2nd 127.7 124.9 High Placebo 1st ... Caffeine 2nd 116.2 119.8 
Low Placebo 1st ... Caffeine 2nd 121.1 128.3 
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Table 8 
Predrug diastolic blood pressure (DBP) mmHg 
Sex Anxiety Order of drug presentation Caffeine Placebo 
level condition condition 
High Caffeine 1st + Placebo 2nd 73.6 67.4 
Male Low Caffeine 1st + Placebo 2nd 70.4 65.9 High Placebo 1st + Caffeine 2nd 75.8 77 .4 
Low Placebo 1st + Caffeine 2nd 69.3 78.0 
High Caffeine 1st + Placebo 2nd 75.6 76.7 
Female Low Caffeine 1st + Placebo 2nd 83.2 74.7 High Placebo 1st + Caffeine 2nd 67.3 74.8 
Low Placebo 1st + Caffeine 2nd 73.7 82.0 
Table 9 
Predrug heart rate (HR) bpm 
Sex Anxiety Order of drug presentation Caffeine Placebo 
level condition condition 
High Caffeine 1st + Placebo 2nd 74.5 81.6 
Male Low Caffeine 1st + Placebo 2nd 80.7 72.5 High Placebo 1st + Caffeine 2nd 71.0 71.8 
Low Placebo 1st + Caffeine 2nd 75.6 70.7 
High Caffeine 1st + Placebo 2nd 88.5 88.5 
Female Low Caffeine 1st + Placebo 2nd 79.8 80.7 High Placebo 1st + Caffeine 2nd 89.7 78.0 
Low Placebo 1st + Caffeine 2nd 79.8 89.2 
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Subjective Measures 
Table 10 
Predrug tension - mm 
Sex Anxiety Order of drug presentation Caffeine Placebo 
level condition condition 
High Caffeine 1st + Placebo 2nd 31.0 31.2 
Male Low Caffeine 1st + Placebo 2nd 25.0 18.5 High Placebo 1st + Caffeine 2nd 29.0 52.6 
Low Placebo 1st + Caffeine 2nd 22.7 27.7 
High Caffeine 1st + Placebo 2nd 38.0 25.2 
Female Low Caffeine 1st + Placebo 2nd 27.6 30.1 High Placebo 1st + Caffeine 2nd 24.2 41.7 
Low Placebo 1st + Caffeine 2nd 26.8 32.5 
Table 11 
Predrug alertness - mm 
Sex Anxiety Order of drug presentation Caffeine Placebo 
level condition condition 
High Caffeine 1st + Placebo 2nd 42.7 43.2 
Male Low Caffeine 1st + Placebo 2nd 54.2 47.7 High Placebo 1st + Caffeine 2nd 49.0 59.3 
Low Placebo 1st + Caffeine 2nd 57.7 63.0 
High Caffeine 1st + Placebo 2nd 47.5 46.2 
Low Caffeine 1st + Placebo 2nd 58.6 50.0 Female High Placebo 1st Caffeine 2nd 53.7 70.5 + 
Low Placebo 1st + Caffeine 2nd 51.8 56.1 
The ANOVA analyses of each predrug measure revealed no 
significant main effects or interactions (F(l,30)<7.56, 
p<.Ol) 
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ANOVA's ON THREE DIFFERENCE SCORES 
The order of drug presentation proved more than any 
other main effect (ie. anxiety trait, sex, or drug condition) 
to be the most recurrent variable involved in interactions. 
No attempts were made to interpret any significant four-way 
interactions on the grounds that they occurred so 
infrequently as to be psychologically insignificant. 
PHYSIOLOGICAL MEASURES 
Systolic blood pressure (SBP) Predrug-Postdrug period (x) 
Table 12 shows the mean difference values obtained for 
SBP in each group for the predrug-postdrug period (x). 
Table 12 
Mean differences in SBP for x 
Sex Anxiety Order of drug presentation Caffeine Placebo 
level condition condition 
High Caffeine 1st + Placebo 2nd .004 -.028 
Male Low Caffeine 1st + Placebo 2nd .024 -.024 High Placebo 1st + Caffeine 2nd .015 -.038 
Low Placebo 1st + Caffeine 2nd .042 -.018 
High Caffeine 1st + Placebo 2nd .030 -.027 
Female Low Caffeine 1st + Placebo 2nd .030 -.040 High Placebo 1st + Caffeine 2nd .023 -.058 
Low Placebo 1st + Caffeine 2nd .005 -.021 
85 
Analysis of variance, revealed no significant main 
effects in SBP for the predrug-postdrug period (F(1,30)<7.56, 
p<.Ol). However an interaction effect between sex, anxiety 
level, and order of drug presentation (ABC) did occur (F(l, 
30)=96.5, p<.OOl). Table 13 gives the mean differences for 
the interaction of ABC. 
Between the predrug and postdrug periods, high anxiety 
males who received caffeine on the first test showed smaller 
SBP differences than low anxiety males who received caffeine 
on the first test. High anxiety males who received caffeine 
on the second test also showed a smaller difference in SBP 
between the predrug and postdrug periods than low anxiety 
males who received caffeine on the second test. 
However, the high anxiety females showed a greater SBP 
difference between the predrug and postdrug periods on 
receiving caffeine on the first test than did low anxiety 
females who received caffeine on the first test. But, on 
receiving caffeine on the second test, high anxiety females 
showed smaller SBP differences between the predrug and 
postdrug periods than the low anxiety females who received 
caffeine second. 
Table 13 
Mean differences for ABC 
Caffeine 1st+P1acebo 2nd Placebo 1st+Caffeine 2nd 
High Anxiety -.024 -.023 
Male 
Low Anxiety 0 0 
High Anxiety .003 -.035 
Female 
Low Anxiety -.010 .016 
Note: Values obtained as the result of the mean values of caffeine minus 
the mean values of placebo. 0 = no difference in means. 
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Systolic blood pressure (SBP) Postdrug-Stressor period (y) 
Table 14 shows the mean difference values obtained for 
SBP in each group for the postdrug-stressor period (y). 
Table 14 
Mean differences in SBP for y 
Sex Anxiety Order of drug presentation Caffeine Placebo 
level condition condition 
High Caffeine 1st + Placebo 2nd .035 .044 
Male Low Caffeine 1st + Placebo 2nd .042 .015 High Placebo 1st + Caffeine 2nd .054 .060 
Low Placebo 1st + Caffeine 2nd .008 .006 
High Caffeine 1st + Placebo 2nd .035 .033 
Female Low Caffeine 1st + Placebo 2nd .026 .060 High Placebo 1st + Caffeine 2nd .014 .040 
Low placebo 1st + Caffeine 2nd .038 .043 
Analysis of variance showed the order of drug 
presentation to be a significant main effect on SBP between 
the postdrug and stressor periods (F(1,30)=16.6, p<.Ol). That 
is, it was the order of drug presentation'which determined 
the resulting SBP, rather than any other factor(s), ego 
caffeine administration. If it was 'due to the drug then the 
resulting SBP would be the same regardless of the order in 
which the drug was administered. 
No significant interaction effects occurred for SBP 
between the postdrug and stressor periods (F(1,30)<7.56, 
p<.Ol). 
87 
Systolic blood pressure (SBP) Stressor-Recovery period (z) 
Table 15 shows the mean difference values obtained for 
SBP in each group for the stressor-recovery period (z). 
Table 15 
Mean differences in SBP for z 
Sex Anxiety Order of drug presentation Caffeine Placebo 
level condition condition 
High Caffeine 1st + Placebo 2nd -.016 -.023 
Male Low Caffeine 1st + Placebo 2nd -.018 -.019 High Placebo 1st + Caffeine 2nd -.007 -.036 
Low Placebo 1st + Caffeine 2nd -.017 -.037 
High Caffeine 1st + Placebo 2nd -.074 -.034 
Female Low Caffeine 1st + Placebo 2nd -.024 -.020 High Placebo 1st + Caffeine 2nd -.022 -.030 
Low Placebo 1st + Caffeine 2nd -.029 -.040 
Analysis of variance revealed no significant main 
effects or interactions in SBP between the stressor and 
recovery periods (F(1,30)<7.56, p<.Ol). 
Diastolic blood pressure (DBP) Predrug-Postdrug period (x) 
Table 16 ~hows the mean difference values obtained for 
DBP in each group for the predrug-postdrug period (x). 
Analysis of variance revealed no significant main 
effects in DBP between the predrug and post drug periods 
(F(1,30)<7.56, p<.Ol). However an interaction effect between 
the anxiety level and drug condition (BD) existed (F(1,30) = 
9.41, p<.Ol). Table 17 gives the mean differences for the 
interaction of BD. 
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Table 16 
Mean differences in DBP for x 
Sex Anxiety Order of drug presentation Caffeine Placebo 
level condition condition 
High Caffeine 1st -+- Placebo 2nd -.016 -.002 
Male Low Caffeine 1st -+- Placebo 2nd .030 .006 High Placebo 1st -+- Caffeine 2nd .049 -.083 
Low Placebo 1st -+- Caffeine 2nd .203 .008 
High Caffeine 1st -+- Placebo 2nd .061 .012 
Female Low Caffeine 1st -+- Placebo 2nd .023 .008 High Placebo 1st -+- Caffeine 2nd .073 -.027 
Low Placebo 1st -+- Caffeine 2nd .023 .061 
Table 17 
Mean differences for BD 
Caffeine Placebo 
High anxiety .167 -.1 
Low anxiety .279 .362 
Following the administration of caffeine, high anxiety 
subjects showed a greater difference in DBP than was the case 
after administration of placebo. Low anxiety subjects had 
the reverse trend, showing a smaller difference in DBP in the 
caffeine condition compared to the placebo condition between 
the predrug and postdrug periods. 
Caffeine administration tended to show greater DBP 
differences during the resting periods than placebo with low 
anxiety subjects but not with high anxiety sUbjects. 
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Diastolic blood pressure (DBP) Postdrug-Stressor period (y) 
Table 18 shows the mean difference values obtained for 
DBP in each group for the postdrug-stressor period (y). 
Table 18 
Mean differences in DBP for y 
Sex Anxiety Order of drug presentation Caffeine Placebo 
level condition condition 
High Caffeine 1st + Placebo 2nd .051 .044 
Male Low Caffeine 1st + Placebo 2nd .047 .037 High Placebo 1st + Caffeine 2nd .011 .058 
Low Placebo 1st + Caffeine 2nd .040 .090 
High Caffeine 1st + Placebo 2nd .046 .049 
Female Low Caffeine 1st + Placebo 2nd .044 .046 High Placebo 1st + Caffeine 2nd .028 .048 
Low Placebo 1st + Caffeine 2nd .028 .083 
Analysis of variance revealed no significant main 
effects in DBP between the postdrug and stressor periods 
(F(1,30)<7.56, p<.Ol). Two interaction effects however, did 
occur. Table 19 gives the mean differences for the inter-
action of sex and anxiety level (AB). Table 20 gives the 
mean differences for the interaction of anxiety level and 
order of drug presentation (AC). 
Firstly, a sex and anxiety level interaction (AB), 
(F(1,30)=65.3, p<.Ol) revealed that low anxiety males showed 
greaterDBP differences between the postdrug and stressor 
periods than high anxiety males. The same was true for 
females. Low anxiety females showed greater DBP differences 
between the postdrug and stressor periods than high anxiety 
females. Sex differences were reversed in the high and low 
anxiety groups. That is, females showed greater DBP 
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differences than males in the high anxiety group, while males 
showed greater DBP differences than females in the low 
anxiety group. 
Secondly, an anxiety level and order of drug present-
ation interaction (AC), (F(1,30)=65.3, p<.Ol) revealed that 
high anxiety subjects who received caffeine on the first test 
showed greater DBP differences between the postdrug and 
stressor periods than low anxiety subjects who received 
caffeine on the first test. However, low anxiety subjects 
who receive caffeine on the second test showed greater DBP 
differences between the postdrug and stressor periods than 
high anxiety subjects who received caffeine on the second 
test. 
Therefore, regardless of the order of drug present-
ation, caffeine administration showed greater difference 
effects than did placebo for both high and low anxiety 
subjects with DBP, between the postdrug and stressor periods. 
Male 
Female 
Table 19 
Mean differences for AB 
High anxiety 
.164 
.171 
Low anxiety 
.214 
.201 
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Table 20 
Mean differences for AC 
Caffeine 1st + Placebo 2nd Placebo 1st + Caffeine 2nd 
High anxiety .19 .145 
Low anxiety .174 .241 
Diastolic blood pressure (DBP) Stressor-Recovery period (z) 
Table 21 shows the mean difference values obtained for 
DBP in each group for the stressor-recovery period (z). 
Table 21 
Mean differences in DBP for z 
Sex Anxiety Order of drug presentation Caffeine Placebo 
level condition condition 
High Caffeine 1st + Placebo 2nd .015 .005 
Male Low Caffeine 1st + Placebo 2nd .006 .026 High Placebo 1st + Caffeine 2nd .009 .027 
Low Placebo 1st + Caffeine 2nd .022 .005 
High Caffeine 1st + Placebo 2nd -.008 .033 
Female Low Caffeine 1st + Placebo 2nd .018 0 High Placebo 1st + Caffeine 2nd -.23 .022 
Low Placebo 1st + caffeine 2nd .170 -.036 
Analysis of variance revealed no significant main 
effects or interactions in DBP between the stressor and 
recovery periods (F(1,30)<7.56, p<.Ol). 
Heart rate (HR) Predrug-Postdrug period (x) 
Table 22 shows the mean difference values obtained for 
HR in each group for the predrug-postdrug period (x). 
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Table 22 
Mean differences in HR for x 
Sex Anxiety Order of drug presentation Caffeine Placebo 
level condition condition 
High Caffeine 1st + Placebo 2nd -.023 -.048 
Male Low Caffeine 1st + Placebo 2nd -.115 -.0l2 High Placebo 1st + Caffeine 2nd .024 .038 
Low Placebo 1st + Caffeine 2nd -.090 .033 
High Caffeine 1st + Placebo 2nd -.038 .006 
Female Low Caffeine 1st + Placebo 2nd .026 .003 High Placebo 1st + Caffeine 2nd -.044 - .022. 
Low Placebo 1st + Caffeine 2nd -.035 .005 
Analysis of variance revealed no significant main 
effects or interactions in HR between the predrug and 
postdrug periods (F(1,30)<7.56, p<.Ol). 
Heart rate (HR) Postdrug-Stressor period (y) 
Table 23 shows the mean difference values obtained for 
HR in each group for the postdrug-stressor period (y). 
Table 23 
Mean differences in HR for y 
Sex Anxiety Order of drug presentation Caffeine Placebo 
level condition condition 
High Caffeine 1st + Placebo 2nd .022 .036 
Male Low Caffeine 1st + Placebo 2nd .021 .012 High Placebo 1st + Caffeine 2nd .032 .026 
Low Placebo 1st + Caffeine 2nd .015 .025 
High Caffeine 1st + Placebo 2nd .033 .021 
Female Low Caffeine 1st + Placebo 2nd .055 .05 High Placebo 1st + Caffeine 2nd .004 .014 
Low Placebo 1st + Caffeine 2nd .024 .031 
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Analysis of variance revealed no significant main 
effects or interactions in HR between the postdrug and 
stressor periods (F(1,30)<7.56, p<.Ol). 
Heart rate (HR) Stressor-Recovery period (z) 
Table 24 shows the mean difference values obtained for 
HR in each group for the stressor-recovery period (z). 
Table 24 
Mean differences in HR for z 
Sex Anxiety Order of drug presentation Caffeine Placebo 
level condition condition 
High Caffeine 1st + Placebo 2nd -.017 -.056 
Male Low Caffeine 1st + Placebo 2nd -.055 -.03 High Placebo 1st + Caffeine 2nd -.02 -.028 
Low Placebo 1st + Caffeine 2nd -.018 -.005 
High Caffeine 1st + Placebo 2nd -.026 -.035 
Female Low Caffeine 1st + Placebo 2nd -.014 -.02 High Placebo 1st + Caffeine 2nd -.01 -.009 
Low Placebo 1st + Caffeine 2nd .011 -.03 
Analysis of variance revealed no significant main 
effects in HR between the stressor and recovery periods 
(F(1,30)<7.56, p<.Ol). However, a significant interaction 
effect between anxiety level and order of drug presentation 
(BC) did occur (F~1,30)=11.1, p<.Ol). Table 25 gives the 
mean differences for the interaction of BC. 
Both high and low anxiety subjects showed smaller 
differes in HRls when they received caffeine on the first 
test session, compared to placebo on the first test session 
between the stressor and recovery periods. 
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Table 25 
Mean Differences for BC 
Caffeine 1st + Placebo 2nd Placebo 1st + Caffeine 2nd 
High anxiety -.134 -.05 
Low anxiety -.20 -.024 
SUBJECTIVE REPORT MEASURES 
Tension Predrug-Postdrug period (x) 
Table 26 shows the mean difference values obtained for 
tension in each group for the predrug-postdrug period (x). 
Table 26 
Mean differences in tension for x 
Sex Anxiety Order of drug presentation Caffeine Placebo 
level condition condition 
High Caffeine 1st + Placebo 2nd .153 .024 
Low Caffeine 1st + Placebo 2nd .096 .233 Male High Placebo 1st + Caffeine 2nd .217 -.037 
Low Placebo 1st + Caffeine 2nd .177 .094 
High Caffeine 1st + Placebo 2nd -.099 .008 
Low Caffeine 1st + Placebo 2nd .260 .093 Female High Placebo 1st + Caffeine 2nd .233 .025 
Low Placebo 1st + Caffeine 2nd .097 -.187 
Analysis of variance revealed no significant main 
effects in tension between the predrug and postdrug periods 
(F(1,30)<7.56, p<.Ol). However, two significant interaction 
effects did occur. Table 27 gives the mean di erences for 
the interaction of anxiety level and order of drug present-
ation (BC). Table 28 gives the mean differences for the 
interaction of order of drug presentation and drug condition 
(CD) • 
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Firstly, an interaction between anxiety level and 
order of drug presentation (BC), F(l,30)=8.8, p<.Ol), 
outlined in Table 27, showed that low anxiety subjects who 
received caffeine on the first text showed greater differ-
ences in reported subjective tension than high anxiety 
subjects who received caffeine on the first test, between the 
predrug and postdrug periods. 
However, the reverse occurred when caffeine was 
experienced on the second test. 
subjects who received caffeine 
That is, high anxiety 
on the second test showed 
greater differences in reported tension between the predrug 
and postdrug periods than low anxiety subjects' who 
experienced caffeine on the second test. 
Secondly, a significant interaction between order of 
drug presentation and drug condition (CD), F(l,30) 6.2, 
p<.Ol) revealed that subjects who received caffeine on the 
first test showed greater tension differences between the 
predrug and postdrug periods in the caffeine condition than 
the placebo condition. 
However, those subjects who received caffeine on the 
second test showed smaller tension differences between the 
predrug and postdrug periods in the caffeine condition than 
the placebo condition. 
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Table 27 
Mean differences for BC 
Caffeine 1st + Placebo 2nd Placebo 1st + Caffeine 2nd 
High anxiety .086 .437 
Low anxiety .682 .181 
Table 28 
Mean differences for CD 
Caffeine 1st + Placebo 2nd Placebo 1st + Caffeine 2nd 
High anxiety .41 .722 
Low anxiety .358 1.12 
Tension Postdrug-Stressor period (y) 
Table 29 shows the mean difference values obtained for 
tension in each group for the predrug-postdrug period (y). 
Table 29 
Mean differences in tension for y 
Sex Anxiety Order of drug presentation Caffeine Placebo 
level condition condition 
High Caffeine 1st + Placebo 2nd .36 .07 
Male Low Caffeine 1st + Placebo 2nd .19 .40 High Placebo 1st + Caffeine 2nd .3 .27 
Low Placebo 1st + Caffeine 2nd .25 .40 
High Caffeine 1st + Placebo 2nd .4 .38 
Female Low Caffeine 1st + Placebo 2nd .36 .3 High Placebo 1st + Caffeine 2nd .22 .5 
Low Placebo 1st + Caffeine 2nd .073 .21 
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Analysis of variance revealed no significant main 
effects in tension between the postdrug and stressor periods 
('F(l,30)<7.56, p<.Ol). However, an interaction effect 
between order of drug presentation and drug condition (CD) 
occurred (F(l,30) 5.24, p<.Ol). Table 30 gives the mean 
differences for the interaction of CD. 
Subjects who received caffeine on the first test 
showed greater differences in tension with 
condition, than with the placebo condition, 
the caffeine 
between the 
subjects who postdrug and stressor periods. In contrast, 
received caffeine on the second test showed smaller 
differences in tension with the caffeine condition than with 
the placebo condition between the postdrug and stressor 
periods. 
Hence, we have an order of drug presentation effect. 
It is not the caffeine which is accountable for tension 
differences, but whether the subject received it on the first 
or second test. If c eine administration did in fact 
result in these tension differences, then the order of its 
presentation would have no effect. 
Caffeine 
Placebo 
Table 30 
Mean differences for CD 
Caffeine 1st + Placebo 2nd 
1.31 
1.15 
Placebo 1st + Caffeine 2nd 
.843 
1.4 
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Tension Stressor-Recovery period (z) 
Table 31 shows the mean difference values obtained for 
tension in each group for the stressor-recovery period (z). 
Table 31 
Mean differences in tension for z 
Sex Anxiety Order of drug presentation Caffeine Placebo 
level condition condition 
High Caffeine 1st -+- Placebo 2nd .163 -.29 
Male Low Caffeine 1st -+- Placebo 2nd .033 .07 High Placebo 1st -+- Caffeine 2nd -.336 -.64 
Low Placebo 1st -+- Caffeine 2nd -.12 -.34 
High Caffeine 1st -+- Placebo 2nd -.26 -.23 
Female Low Caffeine 1st -+- Placebo 2nd -.34 -.27 High Placebo 1st -+- Caffeine 2nd -.17 -.24 
Low Placebo 1st -+- Caffeine 2nd .053 -.24 
Analysis of variance revealed no significant main 
effects in tension between the stressor and recovery periods 
(F(1,30)<7.56, p<.Ol). However, an interaction effect 
between sex and order of drug presentation (AC), (F(1,30)= 
9.24, p<.Ol) showed that opposite trends in tension had 
occurred for the two sexes between the stressor and recovery 
periods. Table 32 gives the mean differences for the inter-
action of AC. 
Male subjects who received caffeine on the first test 
showed a greater difference in tension than those males who 
received caffeine on the second test. On the other hand, 
female subjects who received caffeine on the first test 
showed a smaller difference in tension than those females who 
received caffeine on the second test. 
99 
Table 32 
Mean differences for AC 
Caffeine 1st + Placebo 2nd Placebo 1st + Caffeine 2nd 
Male 
- .024 -1.43 
Female 
-1.11 - .6 
Alertness Predrug-Postdrug period (x) 
Table 33 shows the mean difference values obtained for 
alertness in each group for the predrug-postdrug period (x). 
Table 33 
Mean differences in alertness for x 
Sex Anxiety Order of drug presentation Caffeine Placebo 
level condition condition 
High Caffeine 1st + Placebo 2nd -.009 -.017 
Male Low Caffeine 1st + Placebo 2nd .017 .028 High Placebo 1st + Caffeine 2nd .039 .005 
Low Placebo 1st + Caffeine 2nd -.019 .049 
High Caffeine 1st + Placebo 2nd -.073 .114 
Female Low Caffeine 1st + Placebo 2nd .003 .035 High Placebo 1st + Caffeine 2nd -.082 -.331 
Low Placebo 1st + Caffeine 2nd .031 - .021 
Analysis of variance revealed no significant main 
effects or interactions between the predrug and postdrug 
periods (F(l,30)<7.56, p<.Ol). 
Alertness Postdrug-Stressor period (y) 
Table 34 shows the mean difference values obtained for 
alterness in each group for the postdrug-stressor period (y). 
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Table 34 
Mean differences in alertness for y 
Sex Anxiety Order of drug presentation Caffeine Placebo 
level condition condition 
High Caffeine 1st + Placebo 2nd .05 .22 
Male Low Caffeine 1st + Placebo 2nd .06 .08 High Placebo 1st + Caffeine 2nd .55 .21 
Low Placebo 1st + Caffeine 2nd .16 .12 
High Caffeine 1st + Placebo 2nd .19 
-.03 
Female Low Caffeine 1st + Placebo 2nd .23 .05 High Placebo 1st + Caffeine 2nd .27 .11 
Low Placebo 1st + Caffeine 2nd .08 .02 
Analysis of variance revealed a significant order of 
drug presentation effect in alertness between the postdrug 
and stressor periods (F(1,30)=16.3, p<.Ol). However, the 
significant interaction of order of drug presentation with 
anxiety level and drug condition (BCD) (F(1,30)=8.3, p<.Ol) 
makes a detailed consideration of order of drug presentation 
effects inapprorpaite. Table 35 gives the mean differences 
for the interaction of BCD. 
High anxiety subjects who received either caffeine in 
the first test or placebo in the first test showed greater 
differences in alertness under the caffeine condition than 
the placebo condition between the postdrug and stressor 
periods. Low anxiety subjects under the same conditions also 
showed this trend. 
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Table 35 
Mean differences for BCD 
Caffeine Placebo 
High anxiety Caffeine 1st + Placebo 2nd .24 .197 Placebo 1st + Caffeine 2nd .82 .32 
Low anxiety Caffeine 1st + Placebo 2nd .29 .132 Placebo 1st + caffeine 2nd .25 .14 
Alertness Stressor-Recovery period (z) 
Table 36 shows the mean difference values obtained for 
alertness in each group for the stressor-recovery period (z). 
Table 36 
Mean differences in alertness for z 
Sex Anxiety Order of drug presentation Caffeine Placebo 
level condition condition 
High Caffeine 1st + Placebo 2nd .17 .096 
Male Low Caffeine 1st + Placebo 2nd .034 -.021 High Placebo 1st + Caffeine 2nd -.022 .014 
Low Placebo 1st + Caffeine 2nd -.038 -.002 
High Caffeine 1st + Placebo 2nd -.006 -.076 
Female Low Caffeine 1st + Placebo 2nd .124 .016 High Placebo 1st + Caffeine 2nd .18 .175 
Low Placebo 1st + Caffeine 2nd .065 .089 
Analysis of variance revealed no significant main 
effects in alertness between the stressor and recovery 
periods (F(1,30)<7.56, p<.Ol). However, a significant 
interaction effect between sex, order of drug presentation 
and drug condition (ACD) (F(1,30}=13.2, p<.Ol) did exist. 
Table 37 gives the mean differences for the interaction of 
ACD. 
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Male subjects who received caffeine on the first test 
showed a greater difference in alertness under the caffeine 
condition than the placebo condition between the stressor and 
recovery periods. This trend was also illustrated by the 
females who complimented the same group under the same 
conditions. 
In contrast, both males and females who received 
caffeine on the second test showed smaller differences in 
alertness under the caffeine condition than the placebo 
condition between the stressor and recovery periods. 
Overall, differences were greater for male and female 
subjects who received caffeine on the first test. 
Table 37 
Mean differences for ACD 
Caffeine Placebo 
Male Caffeine 1st -+- Placebo 2nd .204 .075 Placebo 1st -+- Caffeine 2nd -.04 .012 
Female Caffeine 1st -+- Placebo 2nd .118 -.06 Placebo 1st -+- Caffeine 2nd .245 .26 
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PERFORMANCE MEASURES 
Total attempted 
Table 38 shows the mean number obtained for the total 
number of subtraction problems attempted for each group in 
the mental arithmetic task. 
Table 38 
Mean number of total attempted 
Sex Anxiety Order of drug presentation Caffeine Placebo 
level condition condition 
High Caffeine 1st + Placebo 2nd 95.2 103.2 
Male Low Caffeine 1st + Placebo 2nd 104.7 107.7 High Placebo 1st + Caffeine 2nd 104 93.3 
Low Placebo 1st + Caffeine 2nd 85.2 87.7 
High Caffeine 1st + Placebo 2nd 85.3 89 
Female Low Caffeine 1st + Placebo 2nd 66 70.1 High Placebo 1st + Caffeine 2nd 100.5 89.2 
Low Placebo 1st + Caffeine 2nd 112.1 104.1 
Analysis of variance revealed no significant main 
effects in the total number attempted in the mental 
arithmetic task (F(1,30)<7.56, p<.Ol). However analysis 
revealed two significant interaction ects. 
There was a significant interaction between order of 
drug presentation and drug effects (CD) «F(1,30,=12, p<.Ol), 
which is more appropriately considered in the light of a 
significant anxiety level x order of drug presentation x drug 
condition (BCD), (F(1,30)=49.7, p<.Ol) interaction. Table 39 
gives the mean values for the interaction of BCD. This 
showed that high and low anxiety subjects who received 
caffeine on the first test showed a lower performance in the 
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total number attempted when under the caffeine condition as 
compared to the placebo condition. In contrast, high and low 
anxiety subjects who received caffeine on the second test 
showed a greater performance in the total number attempted 
when under the caffeine condition as compared to the placebo 
condition. 
Both high and low anxiety subjects performed better in 
the total number attempted on the second test regardless of 
the drug condition. 
Table 39 
Mean values for BCD 
Caffeine Placebo 
High anxiety Caffeine 1st + Placebo 2nd 180.5 192.2 Placebo 1st + Caffeine 2nd 240.5 185.2 
Low anxiety Caffeine 1st + Placebo 2nd 170.7 177 .8 Placebo 1st + Caffeine 2nd 197.3 191.8 
Percentage correct 
Table 40 shows the mean number obtained for the 
percentage correct for each group in the mental arithmetic 
task. 
Table 40 
Mean number of percentage correct 
Sex Anxiety Order of drug presentation Caffeine Placebo 
level condition condition 
High Caffeine 1st + Placebo 2nd 64.6 66.8 
Low Caffeine 1st + Placebo 2nd 59.9 71.6 Male High Placebo 1st + Caffeine 2nd 78.3 72.9 
Low Placebo 1st + Caffeine 2nd 74.3 59.3 
High Caffeine 1st + Placebo 2nd 58.8 65.2 
Low Caffeine 1st + Placebo 2nd 60.5 70.7 Female High Placebo 1st + Caffeine 2nd 58 58 
Low Placebo 1st + Caffeine 2nd 70.2 64 
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Analysis of variance revealed no significant main 
effects in performance with respect to the percentage correct 
in the mental arithmetic task (F(1,30)<7.56, p<.Ol). However 
a number of interactive effects occurred, especially those 
involving order of drug presentation. Table 41 gives the 
mean values for the interaction between sex, anxiety level, 
and order of drug presentation ABC. Table 42 gives the mean 
values for the interaction between anxiety level, order of 
drug presentation and drug condition BCD. 
Finally, an interaction between sex, anxiety level, 
and order of drug presentation (ABC), (F(1,30)=187, p<.Ol) 
showed that high and low anxiety male subjects who received 
caffeine on the first test attained very similar percentage 
correct performances in the mental arithmetic task. 
High anxiety female subjects who received caffeine on 
the first test showed lower percentage correct performances 
than the low anxiety females. High anxiety males who 
received caffeine on the second test showed greater 
percentage correct performances than the low anxiety males 
who received caffeine on the second test. However, high 
anxiety females who received 
showed lower percentage correct 
anxiety group. 
caffeine on the second test 
performances than the low 
Thus, high anxiety male subjects showed a higher 
percentage correct performance than low anxiety males when 
caffeine was administered on the second test, while high 
anxiety female subjects showed a lower percentage correct 
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performance than low anxiety females when caffeine was 
administered on the first test. 
Finally, the two significant interactions of anxiety 
level with drug condition (BD) and order of drug presentation 
with drug condition (CD), are more appropriately considered 
in the light of a significant interaction between anxiety 
level, order of drug presentation and drug condition (BCD), 
(F(1,30)=1839, p<.Ol). Table 42 gives the mean values for 
the interaction of BCD. This showed that both high and low 
anxiety subjects who received caffeine on the first test 
showed lower percentage correct performances when under the 
caffeine condition as compared to the placebo condition. In 
contrast, high and low anxiety subjects who received caffeine 
on the second test showed higher percentage correct perform-
ances when under the caffeine condition as compared to the 
placebo condition. 
Table 41 
Mean values for ABC 
Caffeine Ist+Placebo 2nd Placebo Ist+Caffeine 2nd 
Male High anxiety 131.4 151.2 Low anxiety 131.5 133.6 
Female High anxiety 124 116 Low anxiety 131.2 134.2 
Table 42 
Mean values for BCD 
Caffeine Placebo 
Caffeine 1st + Placebo 2nd 123.4 132 
Placebo 1st + Caffeine 2nd 136.3 130.9 High anxiety 
Caffeine 1st + Placebo 2nd 120.4 142.3 
Placebo 1st + Caffeine 2nd 144.5 123.3 Low anxiety 
CHAPTER FIVE 
DISCUSSION 
An unfortunate consequence of the present experimental 
design was the fact that the order of drug presentation 
proved more than any other factor, (ie. high or low anxiety 
trait, sex, or drug condition) to be the most recurrent 
variable involved in significant interactions. The order of 
drug presentation was the only significant main effect within 
the experiment, which made detailed consideration of certain 
interaction effects difficult if not inappropriate. 
PHYSIOLOGICAL MEASURES 
Blood Pressure 
Earlier studies demonstrated that caffeine (in amounts 
roughly equivalent to several cups of coffee) can signifi-
cantly elevate resting blood pressure in subjects who do not 
regularly consume caffeinated products (Ritchie, 1975: Innes 
and Nickerson, 1975: Robertson et al., 1978; Lane, 1983). 
The results of the present experiment involving 
regular consumers of caff~ine who scored at the extremes of 
the Trait - Anxiety Inventory, however, did not support these 
findings. That is, caffeine (in amounts roughly equivalent 
to about five cups of coffee) did not significantly elevate 
resting blood pressure in subjects who drink two or more cups 
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of coffee and/or tea per day in both high and low anxiety 
subjects. 
More importantly the present study demonstrated that 
caffeine did not appear to have any additive effect on blood 
pressure measurements with that provided by psychological 
stress. 
The results of the present study of the effects of 
acute administration in human subjects did not support Cobb's 
(1974) report on physiological changes in men whose jobs were 
abolished, the chronic effects in mice reported by Henry and 
Stephens (1980), and Lane's (1983) study of the potential 
interaction of caffeine and stress in caffeine naive 
sUbjects. It suggested that among high and low anxiety 
subjects who regularly consumed caffeine, the combination of 
caffeine and stress in daily life may not produce signifi-
cantly greater elevations in blood pressure than would occur 
with either caffeine or stress alone. 
logic 
the 
Caffeine consumption has been implicated by epidemio-
research as a risk factor for heart disease, although 
results have been mixed and conclusions remain 
controversial. Two reports (Paul et al., 1963; Yudkin and 
Roddy, 1964) indicated positive associations that were 
subsequently explained, at least in part, by the effects of 
other variables, specificially cigarette smoking (Paul, 1967) 
and sucrose intake (Paul, 1968; Yudkin and Morland, 1967). 
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The results of two prospective studies showed no 
association between coffee drinking and coronary heart 
disease (Dawber et al., 1975; Klotsky et al., 1973), but the 
results of two case control studies of survivors of 
myocardial infarction showed positive asociations (Jick et 
al., 1973; Bowan and Rand, 1980). 
The results of the present study demonstrated that 
caffeine may not be associated with increased risk of heart 
disease in subjects whose anxiety levels are at the extremes 
of the continuum, that is, both high and low anxiety 
subjects. However, the experiment did reveal some 
interesting interaction effects. 
Firstly, a significant interaction effect between sex, 
anxiety level, and order of drug presentation revealed that 
low anxiety males and high anxiety females showed greater 
elevations in systolic blood pressure on receiving caffeine 
on the first testing session, than high anxiety males and low 
anxiety females for the predrug and postdrug resting periods. 
That is, caffeine tended to show greatest elevation in 
systolic blood pressure during the resting periods for low 
anxiety males and high anxiety females upon receiving 
caffeine as a first test experience. 
Secondly, a significant interaction between anxiety 
level and drug condition showed that high anxiety subjects 
appeared to be more at risk with respect to elevations in 
diastolic blood pressure than low anxiety subjects between 
the predrug and postdrug resting periods when caffeine was 
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administered. That is, high anxiety subjects were more 
susceptable to elevations in resting diastolic blood pressure 
than low anxiety subjects following caffeine consumption 
during the resting periods. This coupled with the finding 
that high anxiety female subjects showed the greatest 
elevations in systolic blood pressure during rest, suggests 
that this group (female subjects with high anxiety levels) 
are most at risk to such changes in resting blood pressure 
and should, therefore, more than any other group studied, 
avoid caffeine consumption because of the possible 
consequences of hypertension and cardiovascular disorders. 
Thirdly, a significant interaction effect between sex 
and anxiety level revealed that the low anxiety groups for 
both males and females showed greater elevations in diastolic 
blood pressure, than the high anxiety males and females 
during stress. Low anxiety males showed the greatest 
elevation in diastolic blood pressure for this period. Also, 
regardless of the order of drug presentation, ie. whether 
caffeine was presented on the first or second test, caffeine 
administration produced greater elevations than did the 
placebo for both high and low anxiety subjects for diastolic 
blood pressure during the stressor (mental arithmetic task). 
Therefore low anxiety males showed the greatest 
elevation in diastolic blood pressure upon caffeine 
consumption during stress and could therefore also be at risk 
of hypertension and cardiovascular problems especially if 
their lifestyle and workplace proved highly stressful. 
III 
Heart Rate 
The effect of caffeine on heart rate has been 
particularly controversial with elevation (Scott et al., 
1944), depression (Fleisch and Wenner, 1954) and no change 
(Ritchie, 1975~ Stephenson, 1977) being reported. In 
patients with complete heart block, intravenous adminis-
tration of caffeine slowed the arterial rate whereas the 
ventricular rate was accelerated (Semerov, 1923). 
more, since caffeine administration did not 
Further-
lead to 
bradycardia in the 
1912), the slowing of 
vagotomized 
heart rate 
dog 
may 
(Sallmon and Pilcher, 
be a baroreceptor-
mediated effect in compensation for the raised blood 
pressure, or a direct effect at the level of the brainstem. 
Lane (1983) found that administration of c feine (250 
mg) resulted in no significant change in heart rate among 
subjects who did not consume caffeine regularly, for both 
periods of rest and stress. The results of the present 
experiment confirm that Lane's findings are also applicable 
to high and low anxiety subjects who regularly consume 
caffeine. That is, administration of caffeine (400mg) 
resulted in no significant change in heart rate among high 
and low anxiety subjects during periods of both rest and 
stress, for subjects who regularly consume caffeine. 
A significant interaction effect between sex and 
anxiety level for the predrug and postdrug resting periods 
existed. The finding that high anxiety males and low anxiety 
females showed the greatest elevations in heart 
rest could imply that these two groups 
rate during 
are the most 
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susceptable to possible cardiovascular disorders following 
caffeine consumption. However, the present experiment 
revealed that administration of caffeine (equivalent to doses 
of about 5 cups of coffee) did not appear to significantly 
effect heart rate, in either high or low anxiety subjects 
during rest or during a stressful situation. Therefore, it 
would be incorrect to single out high anxiety males and low 
anxiety females as prime candidates for possible cardio-
vascular disorders with such caffeine consumption. 
One could say then, that, caffeine consumption (400mg) 
did not potentiate or add to any changes in heart rate to the 
elevation produced by psychological stress, and would there-
fore in such doses pose no real threat to cardiac function 
during a stressful situation. 
SUBJECTIVE REPORTS 
Alertness 
Goldstein (1965, 1969) reports that subjects vary 
greatly with respect to the subjective feelings of alertness 
induced by caffeine. The finding in the present study that 
caffeine administration (400mg) had no real significant 
effects on reported levels of alertness during both rest and 
stress did not support earlier reports of increased 
subjective alertness (Barmack, 1940; Goldstein et al., 1969; 
Clubley et al., 1978; Lane, 1983). 
However, the 
subjects who scored 
present study specifically involved 
at the extremes of the Trait - Anxiety 
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Inventory (high and low anxiety subjects) compared with a 
more general cross section of anxiety levels in the earlier 
studies. One could suggest from this that high and low 
anxiety subjects rather than moderately anxious subjects, may 
least expect their alertness levels to be effected by 
caffeine consumption, in doses of about five cups of coffee. 
A significant interaction between anxiety level, order 
of drug presentation, and drug condition for reported levels 
of alertness existed between the postdrug and stressor 
phases. Administration of caffeine to both high and low 
anxiety subjects regardless of order of drug presentation, 
showed greater differences in reported alertness under the 
caffeine condition than the placebo condition. This implied 
that administration of caffeine increased subjective 
alertness at this period. Overall, high anxiety subjects 
showed a greater difference than low anxiety subjects. This 
could perhaps suggest that both high and low anxiety subjects 
should consume caffeine before a stressful situation to 
increase alertness levels, particularly in high anxiety 
subjects. 
A significant interaction between sex, order of drug 
presentation, and drug condition revealed an order of drug 
presentation effect, rather than a drug effect for reported 
levels of alertness. If caffeine did produce these 
difference e ects, then results would be the same regardless 
of whether caffeine was administered on the first test or on 
the second test. This was not the case. 
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Tension 
A significant interaction between order of drug 
presentation and drug condition in the experiment, revealed 
that it was the order in which caffeine was presented rather 
than the drug itself which determined the level of reported 
subjective tension. If tension differences between the 
experimental periods was due to caffeine then the order of 
presentation (receiving caffeine on the 1st or 2nd test), 
would have no effect on the reported tension. That is, 
subjects who received caffeine on the second test would also 
show greater tension differences in the caffeine condition 
than the placebo condition for the resting periods. This, 
however, was not the case. The order of drug presentation 
effect was also accountable for reported tension levels 
during stress. 
opposite trends in reported levels of tension for the 
two sexes were shown in the interaction between sex and order 
of drug presentation following the stressful task. From the 
results one could imply that administration of caffeine to 
males results in greater reported levels of tension than 
females following a stressful situation. That is, males may 
well be wise to avoid consumption of caffeine before a 
stressful task. The added tension experienced may well 
impair one's performance, making the individual unable to 
fully relax, think clearly, or carry out the task as 
efficiently in a stressful situation, ego exams or making a 
public speech. This would probably increase other 'negative' 
emotions and feelings such as nervousness, dry throat, stage 
fright etc., as well as compounding any physiological effects 
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such as increased blood pressure, perspiration, or heart 
rate. As was the case with the cardiovascular measurements, 
caffeine administration did not show any additive effect on 
either tension or alertness with that produced by psycho-
logical stress. 
PERFORMANCE IN THE MENTAL ARITHMETIC TEST 
As mentioned earlier, reports on caffeine's effects on 
mental tasks are limited and tend towards isolated studies, 
for example, improvements in simple arithmetic and uncoding 
(Truitt, 1971), faster solving of maths problems (Paroli, 
1972) and adverse ects of the recall of a series of 
nonsense syllables (Hull, 1935). 
The results of the present study indicated that, 
although high anxiety subjects attempted slightly more 
problems in the mental arithmetic task with the consumption 
of caffine, and low anxiety subjects attempted slightly fewer 
problems under the same condition, the difference between the 
two groups was insignificant. 
However, significant interactions between order of 
drug presentation, anxiety level, and drug condition existed. 
Again, the order of drug presentation, appeared to be the 
most prominent factor in the relationship. That is, both 
high and low anxiety subjects performed better in the total 
number attempted on the second test, regardless of the drug 
condition. Caffeine proved neither to enhance nor impair the 
total number of maths problems attempted. 
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Overall, both high and low anxiety subjects showed 
lower percentage correct performances when under the caffeine 
condition as compared to the placebo condition. However, as 
was the case in the total number attempted, an order of drug 
presentation effect occurred. That is, both high and low 
anxiety subjects showed higher percentage correct 
performances in the second test regardless of the drug 
condition. In this respect caffeine could be said to neither 
enhance nor impair the percentage correct in the mental 
arithmetic task. 
From the experimental results then, one can conclude 
that if a high or low anxiety person who regularly consumes 
caffeine is going to perform a stressful mental task, for 
example an exam, and consumes caffeine in doses equivalent to 
about 5 cups of coffee prior to the exam, then that person 
should not expect his/her performance to be enhanced or 
impaired by the drug. 
Thus the results of the present study do not support 
the hypothesis that caffeine administration be used as a 
means for low anxiety subjects to reach an optimal drive or 
stress level to perform optimally during a stressful 
situation. Likewise, there was no evidence to suggest that 
those who have high anxiety levels should avoid caffeine 
consumption to achieve such a goal. 
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SUMMARY OF CAFFEINE EFFECTS 
The order of drug presentation proved more than caffeine 
administration to be the most recurrent variable involved 
in interaction. 
Caffeine did not appear to have a potential additive 
effect on the cardiovascular measurements and subjective 
self reports, with that produced by psychological stress. 
High anxiety female subjects showed the greatest elevation 
in resting systolic and diastolic blood pes sure with 
caffeine consumption. 
Low anxiety males showed the greatest elevation in 
diastolic blood pressure with caffeine consumption during 
the stressful situation. 
High anxiety males and low anxiety females showed the 
greatest elevations in heart rate during rest. 
Males showed greater reported levels of tension with 
caffeine consumption both at rest and during stress, than 
did females. 
High anxiety subjects showed greater elevations in alert-
ness both at rest and during stress following caffeine 
consumption than low anxiety sUbjects. 
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Caffeine consumption had no effect 
mental arithmetic task, in both 
sUbjects. 
on performance in a 
high and low anxiety 
Although the present study failed to find any major 
cant differences between high and low anxiety 
response to caffeine, this failure is in itself a 
signifi-
subjects 
finding. 
However, most, if not all studies on caffeine have involved a 
general cross section of anxiety levels, and future research 
which specifically investigates caffeine's effects on high 
and low trait anxiety subjects is clearly warranted. 
SUGGESTIONS FOR FUTURE RESEARCH 
1. Future research should avoid having an order of drug 
presentation effect. This could be overcome by having a 
between groups experimental design which involves a single 
session whereby some subjects consume caffeine only, and 
other subjects consume placebo only. By having a single 
session one would avoid any problems of familiarity and 
expectation. 
2. It must be remembered that when discussing the 
logical, subjective, and performance effects 
caffeine (equivalent in dosage to about 5 cups of 
physio-
of 400mg 
coffee) 
used in the experiment, this was administered in a single 
dose. When extrapolating the effects to daily life, one 
must be careful as caffeine consumption is usually spread 
over the day. The effects of 400mg of caffeine 'loaded' 
into the system at a single sitting would almost certainly 
be greater than 
period of a day. 
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if consumed over 3 or 4 sittings in the 
Future research should take this factor 
into account when looking at daily levels of caffeine and 
their effects. 
3. A study of caffeine and its effects on the circulatory 
system and the medullary centres should include multiple 
measurements of multiple variables. The present study' 
limited the physiological measurements to cardiovascular 
measurements in blood pressure and heart rate. As Ritchie 
(1975) pointed out, "The observation of a single function, 
for example, blood pressure, is deceiving because the drug 
may act on a variety of circulatory factors in such a way 
that blood pressure may remain essentially unchanged". 
Future research should include multiple measurements of 
such things as catecholomine release and blood plasma 
levels of caffeine for more accurate and valid results. 
4. If one is to study the differences between high and low 
trait anxiety subjects in response to caffeine, then a 
standard definition or categorization of what constitutes 
high and low trait anxiety is required. For example, the 
present study categorized high anxiety subjects as those 
who scored 51 and above (top 10%) and low anxiety subjects 
as those who scored 36 and below (bottom 10%) on the 
Spielberger Trait Anxiety Inventory. There is a need for 
future research to deliniate just what constitutes high 
and low trait anxiety. 
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5. The hormonal variation in females during menstruation was 
not taken into account in the present study. Cycle 
response to caffeine may have very important implications 
not only because of the effect this could have on females 
behaviour (tiredness, inability to concentrate, more 
emotional etc.), but also the way in which caffeine may 
interact with or effect the hormonal inbalance. For 
example, it may be that caffeine exaggerates existing 
behaviour during the cycle leading to such things as 
greater tension levels, and interference with performance, 
than in a female who is not menstruating. Future research 
should also consider what effect{s) caffeine has on women 
who use the contraceptive pill. 
6. The search for explanations of the individual differences 
and interactions of caffeine with other variables should 
involve subject characteristics being recorded with great 
care. As Sawyer et al. (1981) point out, people may 
differ in response to caffeine according to age, sex, 
mental state, personality type, and degree of physical 
fitness. There could be differences between racial and 
ethnic groups, particularly those groups where caffeine 
consumption has been high for centuries as opposed to 
groups for whom it is 'a relatively new substance. 
Information of this kind may lead to new insights in 
understanding 
caffeine. 
individual differences in response to 
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7. More experimental replication of existing findings with 
larger subject samples is important, along with more 
information regarding subjects ingestion of a variety of 
psychoactive substances and their histories of caffeine 
intake. 
use the 
It is important 
same levels of 
that experimental replications 
caffeine and assess the same 
effects using the same testing and measuring methods. 
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APPENDIX 1 
SELF-EVALUATION QUESTIONNAIRE 
SELF·EVALUATION QUESTIONNAIRE 
STAI FORM X·2 
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~E~ ______________ ~, ________________ ~~_ DATE ____________ _ 
mCTIONS: A,number of stalm~~ts whic'h people ha~e 
i to. describe themselves are 'given below. Read each state-
t and then blacken in the appropriate circle to the right of 
statement to indicate how you generally feel. There are no 
t or wrong answers. Do not spend too much time on any 
statement but give the answer which seems to describe 
you generally feel. 
>-
r" 
l!: 
0 
el 
z 
a 
In 
0 
l!: 
~ 
~ 
I"l 
... 
>-.~ 
0 
~ 
>-
0 r" 
~ ~ >-0< Z CD' 
I feel pleasant ....................................................... :.......... .................................. CD (!) (!) ® 
I tire quickly .................................................................................................... CD (!) (!) ® 
I feel like crying ........... .......................... .......... .... ..... .. ...... . ............ <D (!) (!) @ 
I wish I could he as happy as others senm to he ............... :......... .................. CD (!) Q) ® 
I am losing out on things because'} can't make up my mind soon enough .... <D (!) (!) ® 
I feel rested ........................................................................................................ <D <D (!) ® 
I am 'Icalm, cool, and'collected" .... : ........................ ,'........................................ <D (!) Q) ~ 
I feel that difficulties are piling up so that r cannot overcome them .......... <D (!) (!) ® 
I worry too much over something that really doesn't matter ...................... <D (!) (!) ® 
I am happy ........................................................................................................ <D <D (!) ® 
I am inclined to take things hard .................................................................. <D <D <D ® 
I lack self-confidence ............................................................................. ........... <D <D CD ® 
I feel secure ................................................................................... .., ......... CD ® Q) ® 
I try to avoid facing a crisis or d\fficulty ....................................... ' ................ CD Q) (!) ® 
I feel blue .......................................................................................................... CD <D (!) ® 
I am content ...................................................................................................... <D (!) <D ® 
Some unimportant thought runs through my mind and bothers me .......... <D (!) (!) @ 
I take disappointments so keenly that I can~t put them out of my mind .... <D <D c!) ® 
I am a steady person .... ............. ............ ....... ........... ..... ...... ..................... ......... CD <D (!) ® 
I get in a sta~ of tension or turmoil as I think over my recent concerns and 
interests .................. ....................... ................................................................... CD <D Q) @ 
APPENDIX· 2 
TENSION AND ALERTNESS SCALES 
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VERSITY OF CANTERBURY DEPARTMENT OF PSYCHOLOGY 
Tension and Alertness Scales 
ow are two visual analogue scales, a Tension scale, and an Alertness 
! 1 e. 
: statements "Most tense U and "Most alert" at one end of the scales 
lnifies that this symptom, feeling or attitude could not be stronger, 
j at the other that it is completely "absent". 
" each of the two scales make a mark, I ,somewhere along its length 
indicate your impression of the strength of that feeling now. 
Tension Scale 
Absent Mild Moderate Severe Most tense 
Alertness Scale 
Absent . Mi 1 d Moderate Severe Most alert 
APPENDIX 3 
PREDRUG ANOVA TABLES 
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PHYSIOLOGICAL MEASURES 
Predrug systolic blood pressure (SBP) 
Source df F 
Between Ss 
A (sex) 1 1.37 
B (anxiety) 1 <1 
C (order) 1 <1 
AB 1 3.39 
AC 1 <1 
BC 1 <1 
ABC 1 <1 
Error 30 
within Ss 
D (drug) 1 <1 
AD 1 <1 
BD 1 <1 
CD 1 <1 
ACD 1 <1 
BCD 1 <1 
ABD 1 <1 
ABCD 1 <1 
Error 30 
Predrug diastolic blood pressure (DBP) 
Source df F 
Between Ss 
A (sex) 1 1.37 
B (anxiety) 1 <1 
C (order) 1 <1 
AB 1 1.34 
AC 1 1.91 
BC 1 <1 
ABC 1 <1 
Error 30 
within Ss 
D (drug) 1 <1 
AD 1 <1 
BD 1 <1 
CD 1 <1 
ACD 1 <1 
BCD 1 <1 
ABD 1 <1 
ABCD 1 <1 
Error 30 
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Pre drug heart rate (HR) 
Source df F 
Between Ss 
A (sex) 1 1.07 
B (anxiety) 1 <1 
C (order) 1 <1 
AB 1 <1 
AC 1 <1 
BC 1 <1 
ABC 1 <1 
Error 30 
within Ss 
D (drug) 1 <1 
AD 1 <1 
BD 1 <1 
CD 1 <1 
ACD 1 4.56 
BCD 1 7.5 
ABD 1 <1 
ABCD 1 <1 
Error 30 
SUBJECTIVE MEASURES 
Predrug tension 
Source df F 
Between Ss 
A (sex) 1 <1 
B (anxiety) 1 2.99 
C (order) 1 <1 
AB 1 1.09 
AC 1 <1 
BC 1 <1 
ABC 1 <1 
Error 30 
Within Ss 
D (drug) 1 <1 
AD 1 <1 
BD 1 <1 
CD 1 2.49 
ACD 1 <1 
BCD 1 <1 
ABD 1 <1 
ABCD 1 <l 
Error 30 
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Predrug alertness 
Source df F 
Between Sa 
A (sex) 1 <1 
B (anxiety) 1 <1 
C (order) 1 5.56 
AB 1 <1 
AC 1 <1 
BC 1 1.34 
ABC 1 <1 
Error 30 
Within Sa 
D (drug) 1 <1 
AD 1 <1 
BD 1 <1 
CD 1 <1 
ACD 1 <1 
BCD 1 <1 
ABD 1 <1 
ABCD 1 <1 
Error 30 
APPENDIX 4 
ANOVA TABLES ON THREE DIFFERENCE SCORES FOR 'l'1IE 
PHYSIOLOGICAL MEASUREMEN'l'S AND SUBJECTIVE 
SELF REPORTS 
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PHYSIOLOGICAL MEASURES 
Systolic blood pressure (SBP) x: Predrug-Postdrug period 
Source df F 
Between Ss 
A (sex) 1 <1 
B (anxiety) 1 1.26 
C (order) 1 <1 
AB 1 2.37 
AC 1 2.47 
BC 1 <1 
ABC 1 96.5 (p<.OOl) 
Error 30 
Within Ss 
D (drug) 1 <1 
AD 1 <1 
BD 1 <1 
CD 1 <1 
ACD 1 <1 
BCD 1 <1 
ABD 1 <1 
ABCD 1 <1 
Error 30 
Systolic blood pressure (SBP) y: Postdrug-Stressor period 
Source df F 
Between Ss 
A (sex) 1 1.26 
B (anxiety) 1 4.05 
C (order) 1 16.6 (p< .00l) 
AB 1 <1 
AC 1 <1 
BC 1 <1 
ABC 1 4.7 
Error 30 
Within Ss 
D (drug) 1 <1 
AD 1 <1 
BD 1 <1 
CD 1 <1 
ACD 1 <1 
BCD 1 <1 
ABD 1 1.07 
ABCD 1 1.6 
Error 30 
133 
Systolic blood pressure (SBP) z: Stressor-Recovery period 
Source df F 
Between Ss 
A (sex) 1 <1 
B (anxiety) 1 4.97 
C (order) 1 1.38 
AB 1 <1 
AC 1 4.5 
BC 1 <1 
ABC 1 3.8 
Error 30 
Within Ss 
D (drug) 1 6.3 
AD 1 1.5 
BD 1 <1 
CD 1 <1 
ACD 1 <1 
BCD 1 1.6 
ABD 1 4.5 
ABCD 1 <1 
Error 30 
Diastolic blood pressure (DBP) x: Predrug-Postdrug period 
Source df F 
Between Ss 
A (sex) 1 <1 
B (anxiety) 1 <1 
C (order) 1 <1 
AB 1 <1 
AC 1 <1 
BC 1 <1 
ABC 1 <1 
Error 30 
Within Ss 
D (drug) 1 2.4 
AD 1 1.86 
BD 1 9.41 (pCOl) 
CD 1 2.76 
ACD 1 <1 
BCD 1 <1 
ABD 1 <1 
ABCD 1 9.6 
Error 30 
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Diastolic blood pressure (DBP) y: Postdrug-Stressor period 
Source df F 
Between Ss 
A (sex) 1 <1 
B (anxiety) 1 <l 
C (order) 1 
AB 1 65.3 (p<.Ol) 
AC 1 
BC 1 65.3 (p<.Ol) 
ABC 1 
Error 30 
Within Ss 
D (drug) 1 4.76 
AD 1 
BD 1 
CD 1 4.76 
ACD 1 
BCD 1 <1 
ABD 1 <l 
ABCD 1 54 
Error 30 
Diastolic blood pressure (DBP) z; Stressor-Recovery period 
Source df F 
Between Ss 
A (sex) 1 <l 
B (anxiety) 1 1.57 
C (order) 1 <1 
AB 1 <1 
AC 1 <1 
BC 1 1.3 
ABC 1 2.9 
Error 30 
Within Ss 
D (drug) 1 <1 
AD 1 <1 
BD 1 2.7 
CD 1 <1 
ACD 1 <1 
BCD 1 2.5 
ABD 1 3.2 
ABCD 1 <1 
Error 30 
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Heart rate (RR) x: Predrug-Postdrug period 
Source df F 
Between Ss 
A (sex) 1 1.00 
B (anxiety) 1 <1 
C (order) 1 <1 
AB 1 6.17 
AC 1 4.74 
BC 1 <1 
ABC 1 <1 
Error 30 
Within Ss 
D (drug) 1 5.62 
AD 1 <1 
BD 1 1.97 
CD 1 <1 
ACD 1 <1 
BCD 1 <1 
ABD 1 5.02 
ABCD 1 2.65 
Error 30 
Heart rate (HR) y: Postdrug-Stressor period 
Source df F 
Between Ss 
A (sex) 1 <1 
B (anxiety) 1 <1 
C (order) 1 1.5 
AB 1 <1 
AC 1 <1 
BC 1 <1 
ABC 1 1.1 
Error 30 
Within Ss 
D (drug) 1 <1 
AD 1 1.03 
BD 1 <1 
CD 1 1.85 
ACD 1 <1 
BCD 1 <1 
ABD 1 3.48 
ABCD 1 <1 
Error 30 
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Heart rate (RR) z: stressor-Recovery period 
Source df F 
Between Ss 
A (sex) 1 1 
B (anxiety) 1 <1 
C (order) 1 2.4 
AB 1 <1 
AC 1 <1 
BC 1 11.1 
ABC 1 <1 
Error 30 
Within Ss 
D (drug) 1 <1 
AD 1 <l 
BD 1 <1 
CD 1 <1 
ACD 1 <1 
BCD 1 <1 
ABD 1 1.3 
ABCD 1 73.9 
Error 30 
SUBJECTIVE REPORT MEASURES 
Tension x: Predrug-Postdrug period 
Source df F 
Between Ss 
A (sex) 1 <1 
B (anxiety) 1 <l 
C (order) 1 <1 
AB 1 <1 
AC 1 <1 
BC 1 8.8 
ABC 1 <1 
Error 30 
within Ss 
D (drug) 1 2.26 
AD 1 <1 
BD 1 <1 
CD 1 16.22 
ACD 1 <1 
BCD 1 <1 
ABD 1 1.9 
ABCD 1 23.5 
Error 30 
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Tension y: Postdrug-Stressor period 
Source df F 
Between Ss 
A (sex) 1 <1 
B (anxiety) 1 <l 
C (order) 1 <1 
AB 1 1.68 
AC 1 2.11 
BC 1 3.35 
ABC 1 <l 
Error 30 
Within Ss 
D (drug) 1 <1 
AD 1 2.16 
BD 1 2.86 
CD 1 15.24 
ACD 1 <1 
BCD 1 <1 
ABD 1 4.78 
ABCD 1 8.27 
Error 30 
Tension z: stressor-Recovery period 
Source df F 
Between Ss 
A (sex) 1 <1 
B (anxiety) 1 1. 75 
C (order) 1 1.9 
AB 1 1.0 
AC 1 9.24 (p<. 01) 
BC 1 <1 
ABC 1 <1 
Error 30 
Within Ss 
D (drug) 1 5.05 
AD 1 1.5 
BD 1 <1 
CD 1 1.14 
ACD 1 <1 
BCD 1 2.2 
ABD 1 2.3 
ABCD 1 <1 
Error 30 
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Alertness x: Predrug-Postdrug period 
Source df F 
Between Ss 
A (sex) 1 1.28 
B (anxiety) 1 1.9 
C (order) 1 2.16 
AB 1 <1 
AC 1 1.48 
BC 1 <1 
ABC 1 2.8 
Error 30 
Within Ss 
D (drug) 1 <1 
AD 1 <1 
BD 1 <1 
CD 1 1.2 
ACD 1 3.06 
BCD 1 2.4 
ABD 1 <1 
ABCD 1 16.3 
Error 30 
Alertness y: Postdrug-Stressor period 
Source df F 
Between Ss 
A (sex) 1 1.7 
B (anxiety) 1 5.94 
C (order) 1 16.3 
AB 1 1.2 
AC 1 7 
BC 1 <1 
ABC 1 <1 
Error 30 
Within Sa 
D (drug) 1 3.1 
AD 1 1.2 
BD 1 <1 
CD 1 <1 
ACD 1 <1 
BCD 1 8.3 (p<.01) 
ABD 1 <1 
ABCD 1 2.0 
Error 30 
139 
Alertness z: Stressor-Recovery period 
Source df F 
Between Ss 
A (sex) 1 <1 
B ( anxiety) 1 <1 
C (order) 1 <1 
AB 1 <1 
AC 1 3.1 
BC 1 <1 
ABC 1 1.03 
Error 30 
within Ss 
0 (drug) 1 <1 
AD 1 <1 
BD 1 <1 
CD 1 1.3 
ACD 1 13.2 (p<. 01) 
BCD 1 <1 
ABO 1 <1 
ABCD 1 11.09 
Error 30 
APPENDIX 5 
ANon 'l'ABLES FOR '1'O'l'ALS ATTEMPTIID AND PERCENTAGE 
CORRECT SCORED BY SUBJECTS IN MENTAL 
ARI'l'HMETIC 'l'ASK 
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Total attern~ted 
Source df F 
Between Ss 
A (sex) 1 <1 
B (anxiety) 1 <1 
C (order) 1 <1 
AB 1 <1 
AC 1 3.0 
BC 1 <1 
ABC 1 1.7 
Error 30 
Within Ss 
D (drug) 1 <1 
AD 1 1.2 
BD 1 <1 
CD 1 12.0 
ACD 1 <1 
BCD 1 47.1 
ABD 1 <1 
ABCD 1 <l 
Error 30 
Percentage correct 
Source df F 
Between Ss 
A (sex) 1 1.9 
B (anxiety) 1 <1 
C (order) 1 <1 
AB 1 2.0 
AC 1 <1 
BC 1 <1 
ABC 1 18.7 
Error 30 
within Ss 
D (drug) 1 <1 
AD 1 3.6 
BD 1 9.1 
CD 1 4.4 
ACD 1 <1 
BCD 1 183.9 
ABD 1 <1 
ABCD 1 <1 
Error 30 
